ࡱ> g Bbjbjhh K|\|\xuEJ J 8*$fr<PP Pqqqqqqq$tXwZqEPG|P"PPq* rVVVPVqVPqVV6o&p8Spq6r0frpwTfw8pp&wpPPVPPPPPqqVPPPfrPPPPwPPPPPPPPPJ > : PATIENT REGISTRATION  Social Security #______________________ Home Address ____________________________________________ First Name ______________Middle Initial ___ City _________________ State_________ Zipcode___________ Last name __________________ E-Mail ___________________________________  Sex ____ Date of Birth ___________ Home Phone ( )_____________________ Marital Status Work Phone ( )_____________________ Cell Phone ( )_____________________   Insurance Company Name _________________________________________ Address ______________________________ City ______________ State _____ Zip _________ Policy # ____________________ Group #__________________ Phone #_____________________ Insured/ Card Holder Name ________________________ Relationship to Patient _________________ Insured D.O.B. ______/______/__________ Insured Social Security # ______-_______-______ Sex ______  Start Date. ______/______/__________ Co-pay Amount ________ Referrals required? Y or N  Insurance Company Name _________________________________________ Address ______________________________ City ______________ State _____ Zip _________ Policy # ____________________ Group #__________________ Phone #_____________________ Insured/ Card Holder Name ________________________ Relationship to Patient _________________  Insured D.O.B. ______/______/__________ Insured Social Security # ______-_______-______ Sex ______  Employer: (WHEN INJURED) ___________________________________ Date of Injury: ____/____/______ Address ___________________________________________________City __________________________ State ________ Zip _______________ Phone ( )_____________________   Name __________________________________________ Relationship ___________________________ Address _________________________________________________ City __________________________ State ________ Zip _______________ Phone ( )_____________________  Name of Pharmacy _________________________________ Phone ( )_____________________  Address ________________________________________________City ________________ Zip _________  INITIAL HISTORY AND PHYSICAL EXAMINATION Date:_________________ Referring Physician:___________________________________________ Referring Physician Address:_____________________________________________________________ Name:_______________________________________________________ Date of Birth:___________ Current Marital Status:_____Married_____Single_____Divorced_____Widowed Number of Children:_________ Are you currently employed:_____Yes_____No Occupation:______________________________________________________________ The reason for this visit is a result of (please circle): Motor Vehicle Accident Lifting Injury Falling Injury Job Related Dont Know Explain what happened: ____________________________________________________________________________________________________________________________________________________________________ Please explain the pain and location: ____________________________________________________________________________________________________________________________________________________________________ How would you rate your pain on a scale from 0 (no pain) to 10 (worst)?____________________ When did the condition begin?_____/_____/_____ Is the condition getting worse?_____Yes _____No_____Constant______Comes and goes Is the condition interfering with your (please circle) WORK SLEEP DAILY ROUTINE If so explain: ____________________________________________________________________________________________________________________________________________________________ Have you had this or similar pain in the past? ______Yes______No If so, explain: ____________________________________________________________________________________________________________________________________________________________ Have you been treated by a (please circle) Physician/Chiropractor/Physical Therapist for this condition?______Yes_____No If yes, who and where?___________________________________________________________ ARE YOU TAKING BLOOD THINNERS, i.e, ASPIRIN, PLAVIX, COUMADIN _____YES_____NO Name of Medication____________________________________________________________ Have you had any of the following tests? ___MRI ____CT SCAN ____MYELOGRAM_______DISCOGRAM_____EMG_____XRAY______OTHER Are you now or have you have been a regular smoker? _____Yes________packs per day______No______Ex-Smoker How many alcoholic beverages (beer,wine,liquor) do you drink per week? ____None_____Less than 2 per week__________More than 2 per week Do you do any type of illegal/street drugs including Marijuana _____Yes_____No If yes, what drug and how often:__________________________________________________________ Are you allergic to any food (s) and or medication (s) and reaction (s) __________________________________________________________________________________ MEDICAL HISTORY HEART DISEASE______ PALPATATIONS_______ HIGH BLOOD PRESSURE________ STROKE_______ ASTHMA_______ COPD________ DIABETES______ LIVER DISEASE_______ HEPATITIS, TYPE________ CIRRHOSIS_______ BLEEDING DISORDER______ HIV/AIDS______ ALCOHOL ABUSE_______ DRUG ABUSE______ PRONE TO INFECTIONS________ OTHER_______________________________________________________________________________ SURGICAL HISTORY: OPEN HEART______ BYPASS SURGERY______ VASCULAR SURGERY________ CHEST SURGERY______ PACEMAKER_______ DEFIBRILLATOR_________ JOINT REPLACEMENTS________ OTHER:_____________________________________________________________________ Patient Signature____________________________________________ Date______________________ PAIN DIAGRAM Name:______________________________ Date:__________________ WHERE IS YOUR PAIN NOW? Mark the area on the body drawing where you feel the described sensations. Please use the appropriate symbols. Mark the areas of radiation. Include all affected areas. In order to complete the picture please, draw in your face.FINANCIAL POLICYFINANCIAL POLICY     FINANCIAL POLICY We are committed to providing you with the best possible care and we are pleased to discuss our professional fees with you at any time. Your understanding and compliance of our financial policy is important to our professional relationship. Please ask if you have any questions about our fees, financial policy or your financial responsibility. Patients must fill out patient information forms accurately and completely before seeing the doctor. We will request to photocopy/scan your insurance card(s) for your file. COPAYMENTS-By law we MUST collect your carrier designated co-pay at the time of service. Please be prepared to pay that co-pay at each visit or you will be responsible for a $15 surcharge. NON COPAY PLANS- If your plan does not require a co-pay and we participate, we will accept the designated fee. You are responsible for any deductible and balance your plan indicates on the explanation of benefits. NON PLAN PATIENTS- Payment is expected at the time of service unless other financial arrangements have been made prior to your visit. OUT OF NETWORK PLANS- If we are not in your insurance plan you are required to pay deductible and any balance your plan indicates on the explanation of benefits. MEDICARE- We will submit to Medicare for the Medicare allowed amount. The patient will be responsible for the Medicare deductible and the 20% co-insurance, which can be billed to the secondary insurance if you have one. NO FAULT/WORKERS COMP- All Workers Comp and No Fault information MUST be filled out accurately and completely by you in order for us to bill the carrier appropriately. If your case closes and or is denied for further treatment by that carrier at any time it is YOUR responsibility to inform us before your next office visit so arrangements can be made. If the case was denied prior and there are outstanding dates of service, you will be responsible for these charges (unless you have commercial insurance and we can obtain payment from them for the outstanding fees.) Referrals- If your plan requires a referral from your primary care physician it is YOUR responsibility to obtain it prior to your appointment and have it with you at the time of visit. YOU ARE RESPONSIPBLE FOR THE TIMELY PAYMENT OF YOUR ACCOUNT. **WE ACCEPT CASH AND CREDIT CARDS ONLY** THANK YOU for taking the time to review our policies. Please feel free to ask any questions or share with us any special concerns. Responsible Party Signature____________________________________________ Date______________ IMPORTANT NEW POLICIES FOR HADI MEDICAL GROUP, P.C. In effort to running our practices more efficiently will be instituting the following policies: Any patient that requires a referral for his/her health plan is ultimately responsible in obtaining those referrals. We will try and remind you but again this is your responsibility. If we do not have a referral at the time of service, either a disclaimer needs to be signed which holds you responsible for payment or appointment needs to be rescheduled for after referral is obtained. Any patient that requires any type of form to be completed by our office will be charged a $10.00 service charge that needs to be paid before form is filled out. All forms will take 5-7 business days after fee is received. No exceptions. Appointments are scheduled for a certain time and patients need to be here at that time. If you are running late you can call and see if there are openings later in the day but there is no guarantee. You may have to reschedule for another day. If you are on medications that need to be renewed you must keep your scheduled appointment. Any patients that do not give their co-pay at the time of service will be responsible for a $15.00 surcharge. Any patient that does not show for their scheduled office visit appointment without cancelling will be responsible for a $25.00 no show fee. Any patient that does not show for their scheduled injection or procedure under sedation without canceling will be responsible for a $50.00 no show fee. Any patient that has a balance due to the office needs to make arrangements for a payment plan or balance is due in full. Any patient that needs to change their scheduled monthly appointment for medication renewals will be rescheduled if we have an opening and it is in the renewal time period. We will inform you when the next available appointment is. There will be NO tolerance of yelling, cursing or abuse towards employees and or other patients over the phone or in the waiting room. If you have any issues please speak to the Office Manager and we will try and rectify the problem. However, it may be grounds for discharge if behavior is deemed unacceptable. _____________________________________ _______________________________ ________________ Print Name Signature Date Controlled Substances Long-Term Therapy for Chronic Pain A consent form from the American Academy of Pain Medicine The purpose of this agreement is to protect your access to controlled substances and to protect our liability to prescribe for you. The long-term use of such substances as opioids (narcotic analgesics), benzodiazepines tranquilizers, and barbiturate sedatives is controversial because of uncertainty regarding the extent to which they provide long-term benefit. There is also the risk of an addictive disorder developing or of relapse occurring in person with a prior addiction. The extent of this risk is not certain. Because these drugs have potential for abuse or diversion, strict accountability is necessary when use is prolonged. For this reason the following policies are agreed to by you, the patient, as consideration for, and a condition of, the willingness of the physician whose signature appears below to consider the initial and/ or continued prescription of controlled substances to treat your chronic pain. All controlled substances must come from the physician whose signature appears below or, during his or her absence, by the covering physician, unless specific authorization is obtained for an exception. (Multiple sources can lead to untoward drug interactions or poor coordination of treatment.) All controlled substances must be obtained at the same pharmacy, where possible. Should the need arise to change pharmacies, our office must be informed. The pharmacy that you have selected is: Name of Pharmacy__________________________ Phone:__________________ You are expected to inform our office of any new medications or medical conditions, and of any adverse effects you experience from any medication that you take. The prescribing physician has permission to discuss all diagnostics and treatment details with dispensing pharmacists or other professionals who provide your health care for purpose of maintaining accountability. You cannot share, sell or otherwise permit others to access these medications. These drugs should not be stopped abruptly, as withdrawal syndrome will likely develop. Unannounced urine or serum toxicology screens may be requested and your cooperation is required. Presence of authorization substances may prompt referrals for assessment for addictive disorder. Prescriptions and bottles of these medications may be sought by other individuals with chemical dependency and should be closely safeguarded. It is expected that you will take the highest possible degree of care with medication and prescription. They should not be left where others might see or otherwise have access to them. Original containers of medication should be brought in to each office visit. Since the drugs may be hazardous or lethal to a person who is tolerant to their effects, you must keep them out of reach of such people. Medications may not be replaced if they are lost, get wet, are destroyed, left on an airplane, etc. If your medication has been stolen and you complete a police report regarding the theft, an exception may be made. Early refills will generally NOT be given. Prescriptions may be issued early if the physician or patient will be out of town when a refill is due (with limited exceptions). These prescriptions will contain instructions to the pharmacist that they not be filled prior to the appropriate date. If the responsible legal authorities have questions concerning your treatment, as this might occur, for example, if you were obtaining medications at several pharmacies, all confidentiality is waived and these authorities may be given full access to our records of controlled substances administration. It is understood that failure to adhere to these policies may result in cessation of therapy with controlled substances prescribed by this physician or referral for further specialty assessment. Renewals are contingent on keeping scheduled appointments. Please do not phone for prescriptions after hours or on weekends. It should be understood that any medical treatment is initially a trial, and that continued prescription is contingent on evidence of benefits. The risks and potential benefits of these therapies are explained elsewhere (and you acknowledge that you have received such explanation). You affirm that you have full right and power to sign and be bound by this agreement, and that you have read, understand and accept all its terms. ONCE YOU ARE DISCHARGED THE PHYSCIAN WILL NOT PRESCRIBE ANY MEDICATION, NO EXCEPTIONS!   PATIENT AWARENESS OF PAIN MANAGEMENT TREATMENT I hereby authorize Dr. Hadi to evaluate and treat me for my chronic pain conditions. During the course of my evaluation I consent to be examined by the doctor and agree to inform them of any medical conditions to which I suffer from including all the medications that I take. During the course of my treatment, I am aware that Dr. Hadi who specializes in interventional pain management as well as medical management of chronic pain conditions. During the course of this treatment, I may be advised to take opioid narcotics and other pain medications including anticonvulsants and antidepressants for pain. If I have any allergy or reactions to them I will make it known before or during the course of treatment as soon as possible. During the course of evaluation and treatment, fluoroscopic pictures or x-rays might be taken and I consent for these procedures to be done and in the event they can be used for educational purposes at our professional lectures, I give consent for their usage. In addition, during the course of treatment, I am aware that Dr. Hadi might perform interventional nerve blocks or injections during the course of this therapy. During the course of these injections, various medications are used including but not limited to Kenalog or Depo-Medrol. When exposed to these steroids I am being made aware of the side effects including but not limited to elevated blood sugars, water retention, osteoporosis, puffy cheeks, and changes in hormonal cycles; and in female patients break through inter-menstrual bleedings and changes in normal menstrual cycles can occur. In addition the use of steroids can affect the normal hormonal sequences in adult males and females leading to medical conditions called Cushings syndrome in which there are elevated changes in fat deposition throughout the body, possible diabetes, acne, skin conditions and fat depositions in various parts of the body including the back of the neck. In certain males these hormonal fluctuations can lead to mild sexual dysfunction including erectile dysfunction. In addition, the use of steroids can lead to a decrease in the bodys ability to produce its own steroids called Addisons syndrome in which there will be abnormalities, the patients electrolytes including sodium and potassium levels, which may need to be treated short term with steroid hormone replacement. In addition to the risks of exposure to steroids during injections, there are also the risks and complications of performing injections themselves which are administered with the use of local anesthetics. The use of local anesthetics can cause changes in blood pressures, heart rate and possible cardiac rates and rhythms and rarely cardiac arrest. The other reactions to local anesthetic and case reports have included seizures with exposure to large doses of local anesthetics with intravenous absorption. In addition, there are risks associated with the use of nerve blocks including infections, localized pain of the injection site, muscle spasms at the injection site. Especially in the neck, irritation to nerve roots and or nerve damage including injury to the spinal cord (direct needle injury to the spinal cord) are rare but are reported in the literature. Infections in the epidural or spinal canal called epidural abscess, hematoma which may need to be treated with surgical intervention. Injections in the chest area may cause pneumothorax or air around the lungs. Although all of the above occurrences are rare, they have been reported in the literature and you have to be made aware of them as risks of interventional pain management. This consent for treatment is not all inclusive but is presented to the patient to make them aware of all the risks associated with the care provided at Hadi Medical Group, P.C. If any other risks are needed to be made aware of they will be brought to the patients attention at another time and consent will be obtained before each and every procedure is performed in the office on an as necessary basis. This consent is made as a way of making the patient overall aware of the risks and benefits interventional pain management in the practices of Hadi Medical Group, P.C. By signing this consent you have been made aware of the risks and benefits inherent in the treatment. Thank you very much. Patient Signature _____________________________ Date __________ Witness Signature _____________________________ Date __________ Patients Name: _______________________________ Birth Date: _______________ Todays Date: _______________ INFORMED CONSENT FOR THE PROPER USE OF CHRONIC OPIOIDS AND ALL PAIN MEDICATION SCHEDULED 2, 3 OR 4 IN THE TREATMENT OF CHRONIC PAIN Opioid medications are commonly known as narcotics. Pain medication, narcotics, anti-anxiety medications, some anti-seizure medication and muscle relaxants are classified as schedule 2, 3 or 4 medications by the Federal Drug Administration. By reading this consent form you will have information to make a safe and responsible decision and choice of beginning or continuing on long term opioid medications. If you need more information to make this decision, please ask your caregiver. Goals of Using and Opioid Medication and Pain Medications Opioid medications are primarily used to treat severe pain. Severe pain can limit every aspect of a persons life. Patients with severe pain have trouble getting through their every day without constantly thinking about their pain. It affects their ability to take care of themselves, concentrate or think clearly. It can affect a persons relationship with other people who are important to them. It almost always affects a persons ability to get a restful nights sleep. Chronic long term opioid medications are reserved for pain that does not respond to other medications (non-opioids), treatments and methods of handling pain. The purpose of this medication is to INCREASE YOUR ABILITY TO FUNCTION at work, at home and to get a restful nights sleep. The success of using this medication will be measured by your activity level, not only report your pain. RISKS OF USING AN OPIOID MEDICATION Opioid medications have the potential to cause an addiction. This occurs in people who are susceptible or who are known to have a history of addiction. Physical tolerance and/or dependence occur with the regular use of an opioid (narcotic), but this is different from addiction. FOR A PERSONS HEALTH, SAFETY AND PROTECTION, CHRONIC OPIOID MEDICATION WILL BE STOPPED IF THERE IS A CONCERN I will have my medications filled only at one pharmacy which is: ____________________________________________________________________________________ I hereby authorize you to fax or send this information to my pharmacy. These medications will be prescribed by the clock schedule, or to enable you to engage in more normal activities of daily living such physical therapy (prn). LOST OR STOLEN MEDICATION WILL NOT BE REFILLED OR REPLACED. This office has a NO EARLY REFILL POLICY and will not replace lost or destroyed prescriptions. YOUR RESPONIBILITY WHEN RECEIVIN CHRONIC OPIOID MEDICATION OR SCHEDULE 2, 3, 4 MEDICATIONS: A PERSON IS RESPONSIBLE FOR THEIR MEDICATIONS AND NEEDS TO MAKE SURE THAT THE PRESCRIPTION IS FILLED CORRECTLY. Therefore, they need to make certain that the pharmacy gives them the correct amount before leaving the pharmacy. No increase in medication doses will be made without the approval of the prescribing physician. If you take more than prescribed, you will run out of medications before being given more and may go into withdrawal symptoms. YOU MAY NOT USE ANY TYPE OF ILLICIT SUBSTANCES WHILE RECEVING THESE MEDICATIONS. THIS INCLUDES NARCOTICS FROM ANY OTHER SOURCE (DENTIST, PRIMARY CARE, ORTHOPEDIC SURGEON) MARIJUANA, TRANQUILIZERS (non-prescribed) or STIMULANTS (uppers). Please ask you provider/physician/nurse if you have any questions about this. Patients are expected to be on time for all appointments including those not related to refill medications. You may be asked to come in before medication refill for a re-evaluation. YOU ARE RESPONSIBLE FOR ALL YOUR REFERRALS FOR ALL TESTS, INJECTIONS AND APPOINTMENTS. URINE TESTING TO MONITER YOU WILL BE PERFORMED RANDOMLY AND CANNOT BE REFUSED. Please read the educational information at the end of the consent for more information about tolerance, dependence and addiction. Possible Side Effects of Opioid Medications: Here are some side effects that include but not limited to: Constipation e. nausea and vomiting Depressed moods f. mental slowing Urinary retention g. trouble breathing Drowsiness h. sexual performance decrease (especially in males) STAFF/ CLINIC RESPONSIBILITES WHEN PRESCRIBING CHRONIC OPIOIDS: The practice of Hadi Medical Group, P.C. will perform a complete exam and assessment of you prior and during you treatment (if it has already begun). This assessment will involve a phone interview with one or more of your friends and family, after you give them permission to contact them. The practice will not disclose your personal or medical information to them but to gather information from them about you level of function. These two or three who know me are: ______________________________ ______________________________ ______________________________ I give permission for these individuals to be contacted for an assessment and periodic ongoing updates. Your clinician will monitor your use of opioid medications for signs of tolerance and addition. We will try to make sure you do not need to increase in medication. This medication is provided be a SINGLE provider and only this office (either the provider or his designated physician assistant). Your primary or referring physician and all physicians you listed as contacts will be notified that Dr. Mohammed Hadi, Dr. Abdussami Hadi, Dr. Shumail Haque or Physician Assistant Tram Tran, PA-C is now prescribing this medication. You will need to sign a medical record release sheet for us to do this. Information about Addiction I understand that potentially addictive medications are being used to improve my overall level of function. Because these medications can be addictive, certain rules must be followed for my protection, safety and health. I agree to follow these rules precisely. I understand that not adhering to these rules will result in termination of the medication or my care under your supervision (given 30 days notice to find another physician). Addiction Addiction implied the abuse of a drug and is defined by certain behaviors, including energy and time focused on obtaining medications, along with a decline of normal family and work functions. Addiction must be distinguished from TOLERANCE (the need for increasing doses of medication to obtain the same effect) or of PHYSICAL DEPENDENCE (upon withdrawing of the medication abruptly which may lead to withdrawal symptoms). Tolerance is not a uniform phenomenon, and I realize that many patients do well on the same dose for many years. One way to attempt to limit tolerance is to avoid the use of short acting breakthrough if needed doses of opioid medication for bad days or breakthrough pain. Major Addiction Like Behaviors: I understand that if any of the following happen I will be urgently medically withdrawn from opioid medications: Altering prescriptions Providing my medications to others Repeatedly asking for early refills Accidently taking too much medicine and overdosing Threatening or inappropriate behavior toward the practices staff AT ANY TIME! JOINT RESPONSIBILTY: You may be asked to bring all your medications to the office visits. We will count your pills with you to make sure that you are using them correctly and may check the internet to verify that the correct medication was brought in. You will be asked to provide urine tests on every monthly office visit to monitor your compliance and progress We will occasionally contact your friend or family member to assess your function and response to treatment from their perspective If an opioid medication is unsuccessful in increasing your activity level, we will taper these medications and find another method of helping you handle your pain Referral to facilities specializing in supervised medical withdrawal (detoxification) may be necessary. CAUTION: OPIOID THERAPY MAY CAUSE DROWSINESS ALCOHOL MUST NOT BE CONSUMED WHILE TAKING THESE MEDICATIONS THE MEDICATIONS MUST BE KEPT OUT OF REACH AND OUT OF CONTACT WITH CHILDREN OR PETS AND AN ATTEMPT TO PUT THEM IN A LOCKED CABINET IS SUGGESTED FEDERAL LAW PROHIBITS THE TRANSFER OF THESE DRUGS TO ANY PERSON OTHER THAN THE PATIENT FOR WHOM THEY WERE PRESCRIBED USE CARE WHEN OPERATING A CAR OR DANGEROUS MACHINERY I, agree that the above guidelines regarding this treatment have been adequately explained and my questions and concerns have been answered. Patient Signature: ____________________________ DATE: _____________ Physician Signature: ____________________________ DATE: _____________ Witness Signature: ____________________________ DATE: _____________      DEMOGRAPHICS &Married &Single &Divorced &Widowed PRIMARY INSURANCE INFORMATION &Commercial &Medicare &Workers Comp &No Fault & Other ___________________________________ SECONDARY INSURANCE (IF APPLICABLE) &Commercial &Medicare &Workers Comp &No Fault & Other ___________________________________ WORKERS COMPENSATION INFORMATION EMERGENCY CONTACT INFORMATION PHARMACY INFORMATION AUTHORIZATION TO PAY BENEFITS TO PHYSICIAN: I herby authorize payment directly to the physician of the surgical and/or Medical Benefits, if any, otherwise payable to me for his/her services as described, realizing I am responsible to pay non-covered services. AUTHORIZATION TO RELEASE INFORMATION: I herby authorize the Physician to release any information acquired in the course of my treatment necessary to process insurance claims. _______________________________________________ SIGNATURE (parent or patient if minor) Date _______________________________________________ d e f ! / 9 m 룶tjtj[PhV h5CJaJhV h5CJPJ^JaJh5CJ^JaJh`h5CJ^JaJ2jh5CJPJU^JaJmHnHsH tHuhZqCJaJhV hZqCJaJhn[CJaJhV hn[CJaJ&jhZqCJUaJmHnHsH u*jhZqCJUaJmHnHsH tHuh5CJaJh5h55CJaJe n q r u  e 5 = `gdn[^gd`^gd5`gd1gd1$a$gd5m n p q r s t u v w   d e 4 5 7 < = cdefgh&'Z[ðøøøøøèøøøøøøøèøøøøøøhZqCJaJh`CJaJhV hn[CJaJhV hZqCJaJhn[CJaJhV h`CJaJ&jhZqCJUaJmHnHsH uh5h`CJaJ? dh'[E d\$gdZm$ $d\$a$gd1m$$dd\$a$gd1m$gdn[gd1DEF67/ξήsg[PEPEPEPhlKhn[CJaJhlKhZqCJaJhlKhn[>*CJaJh`hn[5CJaJh`hZq5CJaJh55CJaJh`]5CJaJh`>*CJaJhn[>*CJaJ h>[hn[hn[jhZUmHnHsH ujhZqUmHnHsH uhV hn[CJaJhV hZqCJaJhn[CJaJ&jhn[CJUaJmHnHsH u70Mxi&N}$d\$gd1 $d\$a$gd1  & Fd\$gd1d\$gd`d\$gd1 $d\$a$gd1m$ $d\$a$gdZm$/0LMwxhi%&MN|}#$78()*  QR;<UV01ABSTƸƸhlKhn[5>*CJaJhlKhZq5>*CJaJh55>*CJaJha1hn[CJaJhlKhZqCJaJhlKhn[CJaJH8)* R<V1BT)  & Fd&d P \$gd1d\$gd1  & Fd\$gd1d\$gd1( ) C D !!!!!!!""""""""""¶{l{hO1jh\PhZqB*PJU^JmHnHphuhZjhZq5UmHnHuh\P7jhZqB*CJ OJQJU^JaJ mHnHphu h\P5>*hh\P5>* hn[5 hZq5h`hn[5CJaJh`hZq5CJaJh`]5CJaJh)<hn[CJaJhn[CJaJhlKhZqCJaJhlKhn[CJaJ) D !!!$a$gd` d\$^gd1 hd\$^hgd1d\$gd1!!!!!!!!!""""""""""""d$Ifgd\PK$d$Ifgd\Pgd1$a$gd1gd5$a$gd`"""""""""""""""""""""""""""""""""######### # # # # ##############'#(#5#6#C#D#Q#R#ī1jh\PhZqB*PJU^JmHnHphu1jh\Ph:#B*PJU^JmHnHphuhZqh\PhZqB*PJ^Jphh\Ph\PB*PJ^JphC""""""""""""""""##FfId$Ifgd\PRkd$IfK$L$,g  t 634Bap ### # # ############# #!#"###$#%#&#'#(#Ff Ffd$Ifgd\P(#)#*#+#,#-#.#/#0#1#2#3#4#5#6#7#8#9#:#;#<#=#>#?#@#A#B#C#Ffd$Ifgd\PC#D#E#F#G#H#I#J#K#L#M#N#O#P#Q#R#S#T#U#V#W#X#Y#Z#[#\#]#Ff\d$Ifgd\PFf%]#^#_#`#a#b#c#d#e#f#g#h#i#j#k#l#m#n#o#p#q#r#s#t#u#v#w#Ff&Ff!d$Ifgd\PR#_#`#m#n#{#|###################$$$$#$$$1$2$?$@$M$N$[$\$i$j$w$x$$$$$$$$$$$$$$$$$8&9&&&&&&&&'쾴촭 h9ShZqh9ShZq5>*h\Ph`h`5CJaJh`hZq5CJaJhZ5CJaJh`]5CJaJhZqh\Ph\PB*PJ^JphDw#x#y#z#{#|#}#~####################Ff,1Ff+d$Ifgd\P###########################Ff;Ffc6d$Ifgd\P###########################FfFFf@d$Ifgd\P###########################FfvPFf?Kd$Ifgd\P###########################FfUd$Ifgd\P#######$$$$$$$$$ $ $ $ $ $$$$$$$Ff`d$Ifgd\PFfZ$$$$$$$$$$$$$ $!$"$#$$$%$&$'$($)$*$+$,$-$FfjFfRed$Ifgd\P-$.$/$0$1$2$3$4$5$6$7$8$9$:$;$<$=$>$?$@$A$B$C$D$E$F$G$FftFfod$Ifgd\PG$H$I$J$K$L$M$N$O$P$Q$R$S$T$U$V$W$X$Y$Z$[$\$]$^$_$`$a$FfeFf.zd$Ifgd\Pa$b$c$d$e$f$g$h$i$j$k$l$m$n$o$p$q$r$s$t$u$v$w$x$y$z${$FfӉFfd$Ifgd\P{$|$}$~$$$$$$$$$$$$$$$$$$$$$$$$FfAFf d$Ifgd\P$$$$$$$$$$$$$$$$$$$$$$$$$$$Ffxd$Ifgd\P$$$$$$$$$$$$$$$$$$$$$$$$$$$Ffd$Ifgd\PFf$$$$$$9&&&'{())*,t---^....$a$gd\P$a$gd1 $a$gd1 & Fgd\Pgd1$a$gd`gd5Ffd$Ifgd\P'''''z({((())))))))*******+++,,,,s-t-----].^......//c/d/0011)3*33h7Ah`h7A5CJaJh`hZq5CJaJhZ5CJaJh`]5CJaJ h15>*h9h\P5h9hZq5 hZq>*h"hZq5>* h"hZq h9ShZq hZq5>*h\PhZq6...................../d/01*33%4 & Fgd7Agd1$a$gd1333344$4%444447585 6!6Y7Z7[7777777H8I8J8K8L8888888C9E9::_<a<==w>}>>>6?7? @ @Z@[@@@vA˴h`] h7A6 hZq6,h`h7A5B*CJOJQJ^JaJph,h`hZq5B*CJOJQJ^JaJphh`]5CJPJ^JaJhZq5CJ^JaJ h\P5>*h`h7AhZqhhZq5>*8%4485!6Z7[77I8J8L8888D9E9::`<a<=>7? @[@  & Fgd7Agd1gd1$a$gd1$a$gd\Pgd1m$ & Fgd7A[@@wAB CCCoDDEFGHHII J JJJJJJJ$a$gd\Pgd1 hd\$^hgd1gd1  & Fgd7AvAwABB CCCCnDoDDDDDEEEEFFGGHHHHIIIIJ J J JJJJJJJJJIJɷɗ~rh`hZq5CJaJh`]5CJaJhZq5CJaJ h7A5>* h\h7Ahdh7A5!jhZq5UmHnHsH u"jhZqUmHnHsH tHujhZqUmHnHsH u h7A5hhZq5hF7hZq6h^hZq5>*hZqh7A*JJJJJ^K+NPQSRSUUlX[%[&[V[f[g[[[[[\\\|^}^gd1dgd1$a$gd1IJJJ]K^K*N+NPPQQRRSRSSUUkXlX[[$[&[U[V[e[g[[[[[[[[[\\\\\{^|^}^^^^^bbb8b9bOcPcQccccddUdWddd;ek?kzk{kkkkkkk1l3lrlslm mEnFndnennnnn o ooo5p7pq qgqhqqq8s9sBsCsuvv!vvvvvvvvv"w#wpwqwwwlxmxxx^y_yzzh`h7A5CJaJh`hZq5CJaJ h7A5 hZq5h7AhZqTkk?k{kkkk2l3lsl mFnennnn o ooo6p7pqgd18^8gd1 & Fgd7A  & Fdgd7Adgd1 $da$gd1dgd`q qhqq9sCsv v!vvvvv#wqwwmxx_yzmzvzh^hgd1 & F gd7A & F gd7A^gd1gd1 ^`gd1 & Fgd7Agd1zlzmzuzvzzzzzd{e{{{||||||||,}-}r}t}v}w}x}y}{}|}~}}}}}}}}}}}~~~~R~лЧhZqCJPJ^JaJ'hc)hZqCJOJPJQJ^JaJo(hrh15hrhZq5hV h15CJaJ)jhZq5CJUaJmHnHsH uhP_jhP_Uh\Ph7A5>* h7A5>* hvnh7Ah$Gh7AhZq.vzzze{{||||-}s}t}u}v}w}x}z}{}}}~}}}}}}$a$gd1d$a$gd\Pgd1dgd1 & F gd7A}}}}}T~~~~~~~|~̀΀ 68O dgd1m$$a$gdn[gd1dgd1R~T~V~f~j~l~|~~~~~~~~~~~~~$&z|~.0ʀ̀΀ 468h/hZq5CJaJ hZq5hrh15hrhZq5hZqh1h-h1CJaJhZqCJaJhZqCJPJ^JaJhc)hZqCJPJ^JaJ'hc)hZqCJOJPJQJ^JaJo(h1CJaJ3ƂNOPQzƒă̓3456:;<ghimnoyz{ø˸˸˸֢֢֢֢֢֢֢֢֎֎֢'hZqB*CJOJQJaJmH phsH 'hZqB*CJOJQJaJmH phsH Uh/h1CJaJhZqCJaJh/hZqCJaJhZqh1h/hZq5CJaJh/h1CJaJh/hZqCJaJ8OPQÃă456;<hinoz{$[$\$a$gd\Pgd1 dgd1m$dgd1SIGNATURE Date Date Name of Medication/ Vitamin/ Herbal remedy Dose Frequency Route Patient reported Rx Given Injected at practice Discontinued Date discontinued Initials This form represents an ongoing reconcilliation of the patients medications, supplements, and herbal remedies as reported by the patient or prescribed by the practice. Medications not reported by the patients are not included in this reconcilliation. Patient Signature Physician Signature Patient Name (printed) Date Pharmacy Phone Fax "#?@AB$a$gd\P`gd1gd1$[$\$a$gd\P!">?@ABh\Ph7A5>*hP_hZqh1'hZqB*CJOJQJaJmH phsH 6&P1h:p\P= _!"#$% F? \5f_JFIFC     C  6t" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?(((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((V.guBweG /$r-QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQMw+QU˛S6}O:UX#*>G2|uyb ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( PEPE&EQץQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQFG#h(@h= QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQAhO~)~OfV)|16 hgb #@!G'O^NA I6S"303?o,7n^}15{}c9^v;H,gly3_bj_-6^n3O$k;0rj!lky<5~ߵouO_vpqyw#T(EϽzW?ho?\Z$eE #slXy~xg u+x2G=n@nɆe̓D91D~W"~(|Ρ%-e?] om}Ft b)s]L_uKÿ~5xgĚ:6ZPdDb F",Ėj!b@2bOߴxzit 7QJꭧ³`#kyUwmm?㷇앾4kx~d9..(e]JcO? EKg,3+&LRZMsMO(¿)w_-:vg-ʵ[GQ)?g_d&y5_sJ؏߱lm5_|_]ݸe-JoB,|MO9c|k.~ʞ 1<1M.LH[F!>dvy 1@EPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPY4t jZKZ[X5֧ kX 4@'$+L pZO◍4Am}K_hľzKm#i@_?t~?_gni^t ^FAiPD1_E`H1ɯ?ݯs`>6RêxF f5:8atP459~_`6/+MԚW|:_jOyd& ioЎFq^~L?i?GoKனckƟ/5=&i[hТmulp>P&`nӬjI=δ=IRjR(A+/2 kčÖSmfuǃ_/>ȿ-4o__gQmouPѵ#7ڤ*ܙ$1w;~iIO|26yrB'9#+_7~%#~Ǐ&t߲; ^qnt!_~yl2 Amؗo[? ?^#Y5i#oڱ\m⾕5' ='@S=?D @>#-xS]B]RY6sڿ7NG;U>9HZxGlQeإIk$SD,1^Ey<^ڇoJӾjs?hH%ׁ&{]q›wF 䑻9<;e/n[%"8QEQU(((((((((((($?k?_{;w L =+?h?ß"-_7>auVٖy GMc&nK0C{P+7Ə n|W#Eӣ{ Q66l5܃Р[;Gz?/[RԵ;$s{߈4mkQ FKK.$qel97(?|G $񎝫Yw]ii,cyS |Y)#Ꮘ=j?tK/騮^W]?i[Z,Z̭=.MB1;@;_Zþ2X6wڄqI&zaXMEGms sm2dt9 B*J(((((((((((x{o]>ExN.EņwV”{k2,0'>E|ϩ~'|E_Ɨ>XCO^1dż i#bp2x `+ߴlwՕğ IgY3n%(y4|?d?eM#9[4ME|}jDnV3z|Px 4W.`/_z݂jԖ߶s+|5{^aɗEb4E| IfOú| vyi+%17+Ah(((((((((((ci*h5OӆNOPC9\Nᾭ[-0[Av}h'h~K|MMpu,i} ׶.X3>0xWsg^OuCA'+}[/h1.^? )%~*M7t_Exbz|"!A!L6 qtv_ 22dFb9/? c__|jL=ĺiKhvlɠfh*O5/VPkSL-?R4yyJCv"G|O~ziWagG1g vy6_|Z~cNXzv߇-$F)xF nxk²߁oo4kɮ J7r+dv^y~?j'iGi5k>=71[=5χwiD~>VySc p]IIezodVSwѼ@ 9lbȻOO5? i[~񦽭]kw^sa ͠2GE||Q;û_c¾$cۦt/~>_~k>Qh61-,s7Jي0=:c=6f|'O%xÒXGg{cnK+[7Ĝ1䞴~?oI5S.PG]E)#.á'z`8sO 'tӴuR{MoPEPEPEPEPEPEPEPEPEPEPEPEPEPEsEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE|so~~!|E .>]5oq9_4TkwV;gƝb2^w2(?Z+_.Z?oMs!1<\Za&Wvƞ?Z5Է r||gA E :(hl!kkXvr.TB*Z(O(3ogZS➀!9Z~mT6z/$ߋ:D_n*et;|STs;`k L@>N"8]z cׂqŻJ_Ar;߽]=Y|?6Mb-_[Il1~wr?I]RCR|,mmim| +\W:#I1x~8d>zǒ1W6C.~m|S&ƞ|g* JG_C~$>.|%E//iZL$ViFU#.Wp&lvw:׆kd}^ԴK@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@ |o3𕷄>$<%`wM4Hr'~1|,3|Y[OPAz/ዙ?[7+> OlI#WNSguા;a ;]+Ko;em+־7/ H+tqO28O(Z~ZGL* r<տ|>$iͿ''ڨy ]ĩ,~lQ^XjY_[42I"7+)@6VDMVq ^S{,29#mSHn| a? ?&퓪zɏ5%;5tnEAN@R)dZ((((((((((((((((((((((((((((((((((((((((((((((((((= +g߄騪&i&h5D+쿇=Zz =2bWgC×,e=6-ԑȑ^ ~ƋE:((z?\__t٭k[+k;[ȗP랇D~t"_ր5`O^1xWKvG£nxWW_I9<'߻:WѴQEQEQEQEQEQEQEQEQEQEQEPFzE@qEc=h( ( ( ( ( ( ( ( ( ( ( ( ( (P?S?>7>&mKV m4,z _ c _N?iM;CW%|8,�Hנ2)ROKW/ض7o. ־&xNh:&RQǪ'`F0cWP|)@PEPFk(G?WD8͏)a_,?i/sc6Sq\+1rk'I#Y#pFCG:(((((((((((((((((((((((((((((((((((((((((((((((((x>(u8 ÂW%['wN{)g+_:eG<ڿNlm5HgYa0H!? c 3|* |G|Qu·7:.kۻiVG\7W_]<V$yl^o|{Q@Q@8+O xl}66i./&Hk$~`b~ߴ_d|g6WĒM- ;'`& ]P5W g Eq"^NXJn,3_+ҹ g~xfGѴDVv6qDQp1((((((((+A/~ Xzn'ක.> ]k 7zXkbңԮ G$2Z7OcZ]j^S貆_~Ѻۏg\gxOž'mOl&h6,ώߵ3ÿ%?V7MoP#6eI?6h|$$^G_Ɨ|\,ku /|oq?1umڣ|g]s῏&;ov?kѥ & |O1O[/G\$/76}+̿oKU׀oӼkO~=ZM񻹈`$۰籠|rm/1Z~3/9$Zd@B+QhNOl|x#.$MT_ڻx>ZOKtRvn~sg4*p3g~VtmK}ޭ{}mL,+r7@0x |M-COf|/5⿁0M|k f;9x38a_ |M?!l}6R+ń*nɷm~ԟ!_czm/5\xR9n d)8(9 ?`(r="̬25smH~>|&ӼgXYAwk1[@TBvLK3ў,Ɔj`t3EawsE~آNsK@Q@Q@Q@Q@Q@Q@Q@Q@b|G<+-gĺ|{f$eBG+nԬI 6z|WN/4A|Pu:S&i?c8Uœd _ __Jb(ƯO_ o+ndy8BT~(h((PS_ >->3JѶMg: H>TAW,#ɩbдYFI=IUl~,ß'|=_DߋlYy8UAkb?e/|>|ifVahG֊(((((((((((((((((((((((((((((((((((((((((((((((((i^-5Dx.ae]`+-տ5_}g^vT3HLLz.(IJ| ֿS'(j^<X -?$PR0arCK_;6,, Yq>Nlʁ_DQE#t4C~$x--{`"I+?ڗ?ਿUO~$eHlQq8|4<nG/ǟ "[ZkᦓCs> fhWv?FO&Ӡ5 dXzu:REQEQEQEQEQEQEQEQEæ>>O%nXF~P- L.gŭBҾXrվ#^4j=*b >r;d,#9?+f'd#SynyivQ,9+\ކҬi5)fS‘ 4?U GsAtxE /g=M`M 7ï_txWḂ3qyIЎ9Y:?㞕-N3R =P@O('}s[⿆)վ,air^! p|&wZL.t;Fmm8'rF;6KˍWޡ㦷xIgHHѨV/I|o-3FgxomOi Y;F wu%z0|'zO;{KWw5i}(dsQJM~־O|aM Th2C(*v56\Q@7>$xIW>):o巚JڶS!xև_'b+񵦥;LOm%]gANM}a: 0PP8i`(((((((((=(>g9<h;gx7c U4m=Q+k/_i*6?|Y}Vk"vYXaglz]/( |4՟+_ּoiat\yeCF@w_gR~!gw^:|UqڿO!(!X!*"UA_,eʿ6R7$:ƱB@37⾧^QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQA u4dc92?l_ٯUŭ+B/*Wo|:@u"F #.ci I᝜lv35'}[k燼d4|36Я9h*;k[%RHaO -Q@Q@Q@Q@Q@Q@Q@Q@Q@S핳~kY?*|O>#MBEI'[l!E<%#5M_2ڞ 5`䃐HV{kl쭣#4 Ơ`;P[okEzGl`'{+|^\ tx^Z:;Whp?_#~h"剷'=5[C (DP@1@ tڞec(ܥUq}A;W1k&W:ÙM-#Q']K~Y~9ŒZc3j&d?W;IzE$&He c_?|/?"߇z2xY&$VdC h#`ھ~T ot..jO)@Sb/_O~&hyƦa#} NOVPHPm sr_Qx^MprM)?`,V#P*χ?|ѴJͩ[DI `+ `EQEQEQEQEQEQEQEQEQEQEQE@9}:d<⨮ibVT$+ WC5|! d͞iM. #h_'26lĽ]-gWK:,tbA%qd }VQE#cO*v|@|M [ 52Aw,9=+-W^ ^xֽ6ɿTOǃPѨU:ҝ^Oן lg"KjVh X6G#z@ EPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPA8繆#;aTw$?h+_į2f1PZ>O1Nj.xz6 z p#}xwBz~+h` WE \KEQEQEPFh$Qʆ9YHR2 |J1d?ڊIu|3Mt.܌oV\ s_AQ@Tr4o'G?| &3 jq d ײ~Wσ?ϊ/>Qv1+`x-׌~_xfM+WSDΛ+^I(Tiִ؇^_M~ĿT{$7xO[?f6p()-QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQES'+hyTDwsԞAy?fy>xv^M{,X(Bu쓤{c}ݠ"=+M߲yq`I_7xଟ0?<rYnVĚԱ㇎D%Swl+ֿd$o.Sߌo_xr߯};Rʯibc 7)Y ixV6om,U2N}!"5TB=R΀1EPEPQ[_[=+$R)Y#ue#RQ@cLC|`z|bemRcw}D&9;s~_4߳+Xѭ}&!3>D5Gz5LJe=N#ŵD=A9Oߵ/E\CCIbAXg?]}?DO~.k<xmYSbo+}i'{~Tx@i A@{ wCjt^!_vy_H)7#(h(((((((((((((((((((((((((((((((((((((((((((*꺭v4+XFKzj|S?>[x⿈!dKH4/ {P!QWZ׮|E(>mhF 27F+ٯ,?e 4_ 6vAI`AIXI_~ ? ;Dⵄؠncݎ95QEQEQEQEQEQEQE`zQE6HJH5 -x`f7?eeE>oV?B7>?x{U6I|Wvźtj v-~Wգɯ)忋a(/¿(?> ~ح%z$z(oԴ5 y%td`Ag@EQEQEQEQEQEQEQE ~:Ǟ5Kӡ22G|? ?'7!c|➬楣-cG* 8^@Q@Q@Q@Q@Q@Q@Q@Q@Q@W%KoL<0e+{vNX_4~۟Q_xoƭ$þ_#iU6 -.?H50)ΙG~߿߉8L6}|Ef$vk_k?+'독߳QՊm !HsKh-}᭬Zĺb[ۦ=Y5zgLFa!*W(T(P \(((((#*C R@9~L?ه,i."} @-jo/^/mu Z+[C/(˯<񖝬ٰOݤ23Tj $x )lO7Oi>2F[2rDs #f3QwGYOmôi /o'FXF4QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE!8?*o~?l?-?<{kwេL2a2Qې~(Y#⿊qA-'L`=t /7QFj^'kKkD}~ѿno4|7{{yhR&Y;7n?U((((((((iO|}+&V[-WXKnQѡ!8 cސjs@pz-ÆOJ/#M|Z )*¾nm<㿌aOQFM\Фҥa7X͓c'ֿPZ\5J.2=+υ>3 <+jV-{"f=0h(*=Ɨm>HbGU'{M6{ąhc.7-~((((((((Q 0kP _u?5H/kVq[ "58X~6[;0Y*p@#m. ?k>ԭyj7[p`RR22b}+o<~խ5X2yۏ1~8xQچm/7D -\~9}-G_x7Ϗ]մ,e.]@c௃:_77_V7;IS/ڃ⏋B-XcV-c^ ݏ U }Jލo/?φ7+.rcիLB>'gxNڱԵBzIܡJj37⏆ǬwgmUiy h"WHx7>6׵-xZ!„B~V_4|xD.`֭x[\|Lgv:Fʮ }¿oj7ǯ:n5llv9D@ae9 &]AxFZ-BP2_5pE˵+Lt4{-MKE'`sޭ_|+e ӯnmD{,Ϊ0 ԚԠ(((((((( ^|Su3Q _B?^<~3iM>8uo<ܹhPr }GA?S/@̚ |ϓo" #WGNËu~`3嘏|O+?n/c¿t^;}[WVJX܎,9o=_OSӮ & dGQSEPEPEPEPEPEPEPN*/[}hO7n/w͎ǥ-6v]8X⌻5_ƞ5oώQf xWLC}H$:LܹȮŏ?gxsQW>GR|#w`c5|`Z|&E ~|z4mk_M լ>q=^lb#cJ%[is~'LR<20򯶨((((((((((((((((((((((((((((((((((((((((((siP I#PHvd08\\?Lym牑r^+QQY87~%֬4+h|!.?f_|5B=}#PwTҖo txP?Z ᯈmY?RL} k쏆><-x֟ݜ a*?o։q~ DHDB=3_~k > |J&\3/àdU\J?~4x[ğ |x8|+c,B؝Da㊿4ܺW(g_k|9Vyb΢L~A.3m_A~_7{i-2ķ5?V{⽣ >|2h~xIRLeCf:( ( ( (4~'X񧆾O,~#&]51>Xr:W¿⿇$gĶw/ewIٝӜk;$t4x*I4??ea}P]*J]E𭎑If^dC»+`Z kKq7Q Bv ; 5;mU|<"Eg6w%ZH/S+!ު5:|A ,;J!LgucoCO Fhm4KKFk\]id4QEQEQEQEQEQEQEQE`zQEQE`tPQE(((((((((c Eˮ8"X2y!fF? é/Qғm6;t+!?~%y22'Urwvjub|O!}d!:+?g~߂?4ĺ6Ee˓d[ =wT2($mg^OYͨ G%֚l3wr }=[I_GguphW?bjZ[M##@_~{|N)wa^Zn$SH=D @抃N,l ,: S__%nkKonJkL~W7T?_4 MG q~6>|7%ysBu[oa{~+@XTz07}xˏxß#[Fgo>מ8-^y PAbq##Z =oa/5 onKU)!s?Lux6}b"q(PXܚwYXɩ^\Vdgl*,O`~d_om~)Zxw[}9݆WW?it+;{ß &6cL[O^hM]IݕBKkrHukp?/_㾡oj75 JҦs-ơ3d&@~=9nx[ ?%χKA&_*nJl5q ReQjcZP_ rP &9L((((((((?+_4~!s$B8tg5^D!F#UυOj_ g'i'|CRv퉒f_ |'co4 Ӵ p;}h(h{ ے"M~/J*~Z54Qۏ2? HtwteXH'((((((^$0GOOA~Ϣ~/L2:oNiZ_>4PR]4q%AS_m 5Ozg`G%+Dls#5N? Gϟ^&|Gum崖RT(ϯ7"Oi~5 ~Z ?%]ƥ=Hhؼiky~|m\y ((((((((((((((((((((((((((((((((((((((((((=hHRG`h埀 ,h(=^1ھ#5?+l~=Ҭayky\) ?is|iVe?ỻ䑺)2?wud_m,+y=&M03Mr5{q@Q6w⏉^u:xk_[];Oq7ï ?幇ÿu,w]GJ*b߆լ Շ6 ऋh~x-|1{}ڷU@K~ցE"-Q@Q@Q@Q@Q@<4^ NɱL' [W1OIys4`°GZ Q ~>/im=dCn{3O*ʣ+Ӎ\vw>`9$/ǝo|:ͮZv N|bϟ!_//|vu$~m8-hPAj+o8w߱6`zm[I6T@k+-O7 _hӬ?aےZe+@QVq> Ts[пiO?4DXL7q!6 ( ( ( ( ( ( <rԩ#GZJVY{S‹/k|]O6}M@${jO /; Z׋dMm%HHC;LW! J|AKğ_˩7k24zD-޵<-~ݟ/~+K}Qy8#PXs_Z~ֿ7/w뻥^ A#P igYyZ(A v?)_kW#/>%G-j{ks#I9LfICo|д6&@#qqA^ ?8Nt^->o,[ad+T~Z/죣:ڤ,Fv@i;<8|+?f[ˣI9=%h `E̹5%q7|:u|@[wwvX/%#8N=kO_+[G $CY# I1^_> 3NCdaѕ*A(KW{{47:Ѹ$% eWWwsҧXY}Vy|K6=wQEQEQEQEQEQEQEQEP_TO~޿G{kkY@'h#{q荺yP$x_|3៏^ i\M4  24  3E#.}(d?7`:MƉg${o&1ʠ{W?']?]7PIVcK?Rۗ◂>-:}n}/:R=Nuxg=7:8x]>n5?u= g,(!#=ޠ((((((=++u66 4_|5jo+Fǧɏƾ=9ۯ^{=٥+Kv$qZc?11~Ɩlj~%Dԟ WO+P?-ԓAᏌմpN9X=l~ZZ(?;|/ex#V_-o,l~bDI[jm_V~RtS((((((((((((((((((((((((((((((((((((((((( u5Q?߱R{QӃ-֡7U^e+/nmdc$/$p@$?~h_Rc~|1:? p@g TO٣I״$?ߋWB{65T@@:S๺w|Y.n.?kbq_J}?_Q/,1-#1lߚ;+]7DϲG 6\H?B \||W%Kld2JGB~Syscx#_oGthw)cp}5G ږTnzR,(((((smcQ _MʹHc~i0mn.qO~uAۻ Bҵ^p8HbB25GjS <@.ݚ @xрAkkg=/Gů:w <$6v~=_4Pa1o|G𞨺O|3EC['xMÐ@ڲ?6V8>XK?<_bnj[vɂA袊(((((()-CGw.38|{ /7]V+|uO(H<οE+ 0hN5<] ͠'&d'!c rqk*CCbHǩvKK_|*ChXNikS㎗q|\<M+Rx浭Aan.\,Lc|xS[hxz~yDkß>֏akauϊ(ԧlvy⼛ |2_. Uޟk>Ti77Wdz*mᗉ KVH#־3(d> (@Q@Q@Q@Q@Q@~m|1|ïXXsHF~#g=k q8mn 2ǧ W>xg\< ex,Cݑſv1k'}sCiܤ6Un^A/5K[p 1ck:_qGsm/-C+T@ϧŸ-fy 'ԣHP7v56nV# W\ſgoe{0MwO3F0fX߲?-[]X5 RJk!MAEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQH@-]ho?7{E 8Y"7@wOI_‹4Vѡ}zP9eYXbzZwzMீWVjpG*)y(UŒP(̖UE,Ĝ|_"rӭAf)/e(zn 5+ # ¾UA01Ј`˗@FszAO\BH.f;cnG4(p((((((a W_ajuhtx*0勌Wֿ&c#?9彤<?"H1S&Gol&aޛI~&_쏭9קfa{ v}4k4 ocƶ? o?U>'#?3Nh8"A"@x zxF5(l xnr# #Ѓ_4?ލφ:5͇+a[z6~ 9*+ּ /;mo¿1E}N hzO:}g$SFrH [sŸĞݣk7>hS8#}Th(((((((((((((((((((((((((((((((((((((((>&g5Wk^qu4pc_7Y>,s%]sOɣ [ nq@Q8W >"'if PypвC_tWO|;ys&kX$EQEp_? ~|CƷB; M~iPƿ1g__R/O/ӡNvG%-lAݘ6=k"*0|Grx$o|^֩p?ymf_o}UM2r ?w#{8 5>-:5ȁO@QEQEῷ?ڳ«_~#/#VKVHi:5TPOGߵ|I8t[[>~mE>ܚŒJ((( eB7W';)+nҿD4)an"E~zu֟=k:x;:,ΤE¤;ZFM >e$,,KBex9qé  jZ q+*<#.ox BŚ{a>U\޿J|! !w,.|cZ]Ib_]XUL Ϳog>3#mto2޹*qЃڻ:Uw/eլMD΄cGEgC?9v_Z+H9#>)9_K>]6kdF G5~pO_ZƖk}_s;DE~Fh(((((( URD.64vUPGirj ǩۛ{ډȫي UIkCo;~ڰ~w:w,%:S:}ğ؟x, Oz%!p(y4-g}lSOrcQ#ңҵ$c1rG'_YEPEPEPEPEPEPEPQgk%"Bǰ&=+)c3]b}eYW3{(޵SΏ{F>]i<6G~(D\0|ycBCiW/'2Mq1-s_REP~?tٯUwZ8 5ZFkw!/~'C?[|EY= =pxGZm/M/^' :S^ВwCq̈+z%+?iಶHb@:*]`1ҿ2?Jvȭ]/W8oi-5KpvM7_~(f((((((sO[$DA7~R r?qw.빭l gVGO2~uU?g\'W=vzc>@C8?~ޱ#x7Jm[ݔwC*HϾ) sK.5eOd| <~_Dv? ˯K>IJ?w,r W@#ex  o|vG Yi:kMLh=8S]~Wƫ5,.|;%Аx`yDm_jA^-Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@ҾxG?kOY.Mg¤bO@ ǎkk{;wc4,@I+o@?ਟk='M}1SC^[ G">;8*EDP:1R@YGS_B#h}& >!wgY%W߷k>_.^&{w'jt"^-^|QP]S%:uYy0qҀ>_DhvV E{`U('k;dųp73wxrFHUea{b˨^n$R_d_][j o'DnDv3MoT_>i_~xf4 " ā(((((((_,M oVuƙh \;y/cP?eX⋍I wed5־<+/ez6פ<6o33ű|o~K_|3ڬzPxJ?5z.]3l['~8S_\Gn='q_*[ +*c~妏D3kx3UUבa#FOJ&ml Xɥ@𓶑M+~Fi }=AEdq@ cDp1X 5 hXv5Brి #~źk)&Լ Zxmd/z]B'Z OBʇnv6#ұR((((((:4/^(O |$U,i#s|E/-⏆,lvfEˑP_584E cssx%bkck cE}|Y'_%p;/<}k+^&MGڱE,q!}[>/}gcF\aJ~EFh(((((̞dM~_?JĞ~Vӭi༎gzWg+iN+㯅-&(TTWPv!=>x׉Xӝ"Vv`3upWF,E?\x^Ip1=z@EQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQHbp$xWӊY3%HQ 5?cL<XIo^"^̒7$̿_R ix.GE{*z %5 GQ\Ck \Hgv8 sR_TjxcMпcO?C+OL`c"6b*GeO׏:D& [qKdjC_qđFF `^k">_C-[›/~6_?hƟy8DwuPE~|TmCᧈ,K z 5XA_翎[?6 4wEP2nx_)|?yxYkJ$ApGBH`KkhV8"( (O%'OvʹNߕ ( \6~Y Gqx~-B,eIUz_M_fjC^Ɵ־:<᷅c6~#(Ш() yLz Z~??:·0b\7J\#-v=j((+K cI㞒~_V_5Sx6+[6dVBe0sZ;lG4mYH`GP{Wg<1.Y@|#٬v+28F9_ Ꭽc.zNj\J8Q|a'%S_:]z]%M")UXeZE<9\PoF ~)O.b,ZVD9ޅ-=+kKHV+x!*(EPH)h=:?-o*7k6h#FQҾ9-y~ Λf7951Z( ( ( ( ( ()u & b<(7+SZjxN9?_~ -?5:jP@l<]|zl0?yT斐zREP~_Ol¿[DԔ~2bO^J~ 鷸zkU'5_.=ii 1znGumoyBG"tq"K@-o=~ßybW~qgr1f`OzS^%UT Wo|EWeRʩ/Cp j_G;LW ,Ciҽ4|;Gr# 9k| ;"ÿ F.ubּ?u{ZRLм.?y$xQxi~?gedڵ57]Ib\8~[Şϧ_F(~ekxCxClʅW6%$ *8cο8?>0߿Տ[Rƛ\>/̜YڃZ# |=G {gz:>$_7E@B v9 7#N{ÿ_DfnAx[r\ڀ=?|~~ ߄ <7oZl $20c'&zE(4OI _^El63_k,Ƈo 4#`O.+w'|i-Vgl,n { ^ܰǾ5(()dTlu.@-4 )U薚.QC'((+ ͣ[Y_ޥi`#DeOٛW~h_>iwBo%Ĉy(Šln(ulPAPFPTZml%_',oè١-}۸{ס8_m>&9Z/i70=FG\wԬX''`E~D6C*?;eG ƍ3xA+{?'|*֣F\-q]U嶡g$SF7CFA#.o^(lOr}(B]BbUھΟ,{m1]|3 u?Kn%柶K:Ǜ1cf|L_9|QYX;+ 4պfgl𚏄|UYz畯Ep 8 4(MQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQES.xm4ʄ8@~1|-|oT~>0Pyd{TWk'>ҨK޾?X7wş>>'j_,R/D ~n;k'o.EA?omrC#C,Cv>@}'ۍEIMB @0`SھgiW:3w|= q Ҩ#(]|I85il)qm =A_ה߳1CK\/IS/A\ m5o;w}KXsykh2p?x? xF|YŸm#e?G ~|;ko3Nң|oKU8#ҝEo |i|Ri%]*k?b{][↿k ̮ z) LQ>V/ןm05Í&u4,9 rUu?i?g.ˆ 6ےkh(##f?9>k2~^kV tφd\q_kYirKKwp Ҁ ( ( l*u6_*gkugE0k5_MX T"} 9s[q~EPEP_p'V9x[ul;XF`9A_7pO5 q؄c@P' q^G'[Sž!̎Ok(^ ?dŶPltu=2 fFS}>&ѡ/?re-] @;!>뿴ğ2.:)ҦTv8"ϋχ˃QZ7F̪F_zk|N>l휿.Ю4/ i.eA[^N |&3pG_)FfZw,R41:WwhK5*|o ~+kW63Gڜ[Vj i_ Y+ԜvM$rڀ9k(@oŚGQm×٘%UI Xý~ʊ{ ykMzzK l7#~`v((((((((((((((((((((((((((((((((((##{F|wu+!$Wk'yLn_-ҿ+?g|W 1V|TKxmtq 9}:~^Kh@Lƒ;8-F><={eumum(x_Ua}Woş~v[fIe-N=[o5'!? ˫k+MG@eLQsY@>|1}gzw-~S*/u26?48VE!r?&{WshGbO)ޅӆTrۊu&ȇoC>!T->-.Dmp$zo |=}[|a#\N7#4BG4b(+g _nL`¿iJU6>p퐺m)jl@X((lZ|)7u?B)=kCthKkiN;ƀ|mľg .:Q-!l4O2s_RÚG|7}}v., I-dI)O_?O] gq]Yxb}Le~4Qpzvv|=.>\EڟELK_yXOox+ )9Zg.cg|=wϧ O$BzTf_ID |U]VnDh4(30=翎<+K<`|VѴ\)6?>xZX^,tm#dcE}EPEPEPEPEPEPEPEPEPEPEPEPX$uO#VW!Cȭ(8@=[}7 $+#= }%V [ .#ppv*#eO|Ee5 8ڛL4jCMOc|m G%rGtT1K;sIߌ0j]8>6V^\6#6w> {u[xV[υO-"US̥zd+ʾ_iOR$ ip6緍rEzWo%)5i? 4\k7kjO݉A%~=4XF:(("c (Mo٣\v6b&=4w9ٶm&5`2+J ׏0zQi֑pqt}_TQUK,4`iZY5 8s~" >>&XGy|]h֖j`0<WK|{/ښ9Pe ;FWگm|I^@ug' k>o*፜>!< Zk32P$$/goT?=^{94e6y[Y %__ c-<ԚEO0yѺPo_K/f"5KVT񿄴VHDޱ[دX';ote[LGl=(+,_ޥ|4D<~% j~߿1~>?1PQ_?_T/_L΋K3kZifGq+H2I޽'F23@?;A&x̳ʨ1jυÝO'-euH4˩WK9eCk?Q#}Ᏽ?gE02_?MaiIqWhnFI>|T^PdeOSa|A% xſ<+d\}[U9j|?Uߴc~lNgCkS9xw x :{k 4p+h((Hv3xEv3|a0uWNG{O|LԮ>}̎_~((㩬sjw2kKI$x+g9_~?^ k~+lxIO0Ž/ P߲ ;IM߇la$EBh#ҼBR~^HŚ$`WEPEP_F^,.g-οp!O/;j$.yuא<(D dR)i{Z((F ߟ?m/~ןOt-@DZ?}gP4vF8@DO>AAPgƟ>:i㿊tOx%PE8 >k8ᛑzYKI[Zƕi#,Ur[+g~?WK_xZlZ66>#ky"$C} yQ[[Z[ۢdP?K@Š((((((((((((ӊ(@?5O_\~Ѧx{BX1 f7T/ό/> м469>V'r~]Dũ;Ix78_ZFHm]I0@lA7WWZ_k+[&I QsoGhڳOY~xZ:xmH"egdk"/{츂mO]ܾXyv>Ex3Btmύ~"Oѭ%V=9"5+/֓U񟍚h|%ixMKIV(#v3~W~ uz1Eyr\$*Uwt潆 ( ( u/.Nz3kث?o6c~x䈹 E~+Q_/,%׃鮘KZdW_Kaw~_4&r#uR.Xb+2~Ͽm*LSKQJH#e$k>8o}&#\nOjX"85Sn63C=;Zj&x دuO#kᆳqhơ]*vx!D".W;v~iy-Jk [}'ICQjqѶ%Gpq g<~,xٿOmCGi>tim ڕcaJ?s]{oڃ/ &x;iS__K2f 5G@^<8~PŚ j|{vV`*+ ?7 qS3F3f1sP_uo0&f5xs] Z1Fǵ-W1.>\~1džn1_uO2z]g4\NSwFqN$KpHmH' `̕QEQE!ο+&y;~?lo{`{~#a$qЀϭ~[ǿbh7$eivQoo"t@$-y_O{FClmMk\\|©p;Tׄ5߆_Uw[YMu"]}?Z~ٺQW<]w[v?ë=6Uh]瀶X|%. R|W̳<9WKkW56|dP?K/ğL Wn'x@Ӯnڽ~~^+(r)?Q ޯ/K~=¶X]F}fCe?_!&m~&cf&9ڀ>(((((((((((((((((((((((((((((((((((aԴP>'|K>wS]鑻9r15>{OIt{+hW[z@Q@Q@Q@#ƖE~x1?TڟnWv*p9_CR>)oqY^SG5:+(aEP_&j=xs]zյ Ɩ]B+#kpx}fzWG@k}cO*Mݷ?6+[D :m9}*|H??g/|Fi"w|?k4.cPs^_3|QvxO׺Mx6[\Ȩ;O_hEPEP_EM>{mU>A@ෞ ~"CK+URX¿,6? iFi/>#]$Ol@A?SQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@PT/'Kßگ_񖟧xl-uf!.]> W |o{:oO||ԼGòšKSGk>Qe&сֿh1MW4m+[6ZƟ -+ :lFEKCd[Ǎ.jK@;p_?~z2^xVvj"MF3#$otxCE\>~Z" ՠCU*:(((cU|Ue7LɁtX-YNI&G/hzJkkKtȺjÿ6WH??am8jĠ((xRѴ;Vp5vMß 믃~#Z$kw[1_nbwB̊#L7>i~@Q@Q@ҿ2? #!پ1ڟĹdͼ8q~T،)$iOz ]EU}9m21u mXi߱Om.tUʸak((rQ@,~_ ?hĚg'h~b{5,:r.Y # _$ ]ǿuhz}%C j0EQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE(4_շࡿOǸ [RVKj^ð~ƛM_?kܜnt8E}w?ǣ Gy[^?yu4QEQE!8{W篍_^=DfT›4LܽFU;m8Ц ub1kV0:i>H|Qɰh - Wti%X"x [{ ă_w zb;O8K%KySq_xEPEP;s6 _ܤ1i5I!"fDcXVf/ߵv5o=OQ_:`C+:yq1eOgouN㑅ϯ$QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQER8VB8#4Ҁ?LJ?Ŕ[X xnW~Z)ߵІt;x-[RQEQE||&'7.Dg8 ]}|/mL Xj3֞2Co;zx~4/bpD"7lGjw@|;[L|U:𽖹]߱-էEEQEQE3tZc[ϋQ[,cnzWn~/Կ٤٥ܓ|Pկ q1"os@^ܟOi%.GfֻZ} b ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (<@d/_ `I5 ]Z+;e13?#oĻ?㽐 ǝOBkY!+#"@N??f(V#'ۤy%j((;3_ /o,c;ŻGV%N[90b>#kfLWU@CҾ.~ٿb)H7kne@PJZC|1"τ>$2p*O^q_~wSցcE6=7?־Eo4 zt%X&Ez~'?~!6}_2 JƪzmQ@ŒZ+7!𗅵/^2XT]Y_ xA w^)f3sf}С@p8ϟ!ofxeOBC O?{>@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@#gRFF(H|[5Ԗv|ttqj+zWҐFE~{{;y"A'NX޾.)ҮQ rYAjEQEWݷƿڿo_mp>XRkORP1ic=DQ>dN|(PDEOe{cB2WLf WR4nyo.']~OX47\3hr((fURK5M?l?-g+<$_|? ed+(e@V#5Uoǿ/oxGү7j dea- q_B#S~#s Iv>wy$cIY^}KEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEOC_{{?hO9uhw W[0f_ cb|Cv7 \J |(t (<7*]ӥd7-PvbsZN[$*B-s#^|6GiR(|-r}6.Z9ʰfC;o[=[2;=8ki~*#o7 - bp\~eoz惨.aҮ#{ھ3|u 'o!x~#TQETo'D֣*Lp4?#k&k&+p:?,U!%­GEHWЅY+|6??C?h(((((((((((((((((((((((((n//5-S E)hHpk/$ᦷ_-,} SNeҶ{ڿE_?C~ ~Tki.f&OBXr3E"(56^ψzj~d 2[(4Gq_F=?e'O~ROTS .,O.ZU6ZQI;^ke|_7^~׊N3qvM]&E~XXy? c<@EPEP??/HMCQWĻI/l@v(mL x[M-H㲰DP@WgOk?ߋit_I?2Z\$(I(C ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( 5UN?a/6_~WO _M oe9ar d#>P:Q@Q@?T mT̀ޭ4|/}؏oH,on8oבq|g{s,߳^#G-~e| ~xwΠ6ZڸĪQ@>*cQu?? ,]8e㘭Gn=Mf7v?tԏ_ ݗƯ6!oęm:y?}EP_?qƃ?a2-,|KfAj|Mk_{Eu }L^2Iͳ:rEz!#:zMΣ.dFȰ }0AGN(ϟ!O E|.+,-6ʫ&AE~W_>g?+'¯ړR. "Aw7 $ݱ@vQM:AP_t rN-Wƿdiwʊ>#a_UV׿Qt.rq? 5GO?h((((((((((((((((((((((((($|QFͿ P9&\  p1_^o ;α$t|XX@)ԋҖ (PGUx:ەK溺hTD,I'?xǏh-]G=Me#Ep"=Fֺ- ';o x Gm+J[7K­|+ؿ`RN+sƓcܔi@g+y|o?i5@-?>cj>xT탂UHKDÆR_ !/b]C eºKԝxAE52G?: e{I\wGALo#c_?G?H?1S(((((((((((((((((((((((((((((((((((((((((((((((+k+ѷ wnoY}Ȓr+P!lf$6#_?mxu-(~I1TʧEPUMۺH4:n`Uh_/&8 D{&|ѿ U`}c.>T6>11ȠΗ(Y}wZ q9`.?c_vß[_ A#[X%fD21ROo:Í,5Ĥ5Nk?¶e>͔)$  Р( Z /$>2hzb@yW \ GJ[$bu83VҼ!Kmm]G*a_p+~ ŗI*Z?8 mǵ}(k }*?-Q4xa7>+J:vηÚ"2M?})÷Ӟ&sKUym, ĪXj###taN;?-\ڣƓ7! *tJK8WH#գ,0#W}M0(QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQExe4]G@?l?URoYɵNFy+KȋQ+)mkchZaf* V~ER7NP꿳+C(ςಅ "فwo[M~ | F5f#xH q}e_/]wֺᴚDIAti@|F QE_2?VM^^;ӿc?חQZtU:'/>ذ1z_C.9 j ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ojXbK˗(]R~j~1x gc[y$Np ԴIEPH܌RFhw; M xo^&4m_X=xt?4|Tl[Pu\, f!W8kK?f|@Z=[6w?iw^%$_Y50he[cֿG.'¬hY<kk Qj7?'WUVxk1hZ'ZZ(Z(H/7xo?gi9@nX5 D|gӷb#>S>k؈-(XQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE)SWiz'K{ k $kwl1{C}~On~q5#P`mܒ#xLO)h(#aWO =!W?٫Vkφ,i4Lی20@ǽ|a۶mDMDMxl;Gր>g^Hyw8*|?SѮ~"ů>X_p!%+cC^s{;?~"F/E6 #*s0ƺO''9gؿ_ ~e`oޞKq,,S[++C%zZx4WW+cr̜~Qȯ+O.u72GĢjP"WՕ+(stի (((((((((((((((((((((((((Y,),eg<fyt- ji:z*)=g[= q!WlPHj(((W=7|'e-O,ek!WHk]3Plو_%2^$@IP~;E:~&Ck_ ]&!sG_w./^~{๯>7௅VE3x▍ʠϱC_c7𥷀*-'L4^P(r((kL|hēng4u_Jhe ی}T"!QH((((((((((((((((((((((((((((((((((((((((((((((#5sR=D"e'bKT|=|d>Cq,'gpr>n-xY#)ԟZWǖfxOR5? i˵s^Fh(6Od?LolPwke$,@?5I{.ǞW_G\MrZ!VȠ ]R4__#l#EOlE|G|/La~x[L| ( ;ƚ\c7gm}_^k[?soP۵kJ!Q?;R><g?ѭd[;XGQʩZ-m#L} @Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@z_| ӓedkoȕ &,_|;~~h>xHl Iؒ`-\Җ (W<6l^ &$ͼxW5 ~)Geo$J&̊FA@z:<&kK&nBQКJԤ~:V}FTu*<)>hQERgZt xOR>}M<ϵP*h_ѵ?}i]ֺm<L~8_uk>9ѷNPH Q_n$(QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE|mu]K/:j5HF(o!GšN#./j=b+H1Q+?aoy,;,| ۭ}:PEZݯx,1.ۉ-DU?67ױjW,g~+?G\<ONa%=IrJ¿C~𵽠4Bn͑*|Os_a!K5nV:5%ҭ} j|YOW-eCg$ÞMvĿ%&G]EP:tY?׋% Lj/lndXCے9b3ڿ~ԅïL8ۜxᇇ.~|!- u>ݗ'p@i5Me٥ŬцA:? j'lO&:ovfS#4QEj'/n[#⭆.89G@g_J7ſ5i]S<>?Cu=xLJɭ|TMΨf1$~k##@T-ZWo㡸e?1_mz[Z_~^ϔ/zV6.8~x|]DJL GKH!l΀7(+-m37gFq=3Fd2kZ ş?[\嶵>n`1Z$: -_iQk3I@~WەK%+/iф "v ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( B >4M=5!d[~:q_u? ?ȗ<96Wc=/qW~~4Ļ=A.[Vd`vc Gwh@Ag'_)MҚFŷE73_wij]XhQ,߃9vk8J_ _M./#3MAzQ.0T/+^wzV|bWȮ6x5EU÷SzMQ@>: KӴ8ˍ|{Fx ULsf o9jRA8-xX~#~%>3!9 $@}z?5'i|Y^$:lPB#OV>a>H|-.^[ ĭ gcW@bF_k{[mSc4t}+@8\l.uo?vF}Ⱦ5@H$OA3Z-lyҟzOn+/P꒣̾ o݌cX$.bfF@@oe {kY L)L[$*HyGZ$XX@ ;WN7Vzn.o?N5̰Ŷl\9dPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPU?v?!Z nmt9u=4-Ͳ+;b" %'.wԴ{kaպɻ&ԴMVm2e6hd:__K}b/|k|UHt{PaJ3<ȃ*~o\56 C+xJLuO9?ҿHJ\Eh6nViaMѠlu>]O?4~5>t"Y|GG&{~ o<`| /.~soƋlk3c!|,N]Yub-7xA=h]Iϊ1|G]4|HԒ&#Z4rb?;JvlZZ|6Ɓ@X { @4ڣ d׶֟ E<;p`L5jקzZ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( 3߇ >~Zz_9`dG-*M?8὿o%ߍXPK}c>; x.Wwy#F+/$t%.yk:> æ|$gC_l |s 7?&.[H-9:$xᇈK!ǔ껃،W} Oj34%;䕷A@[c%Մg[-ţF\s)k^!,?^>Kw;H!oC⾔& k?Yh;*ig|K 7CwOyz%|quºSԼOqe f? 'ls'ψ|J۵ڮ'y/8dyg|bnn RkaEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEPEP_S_-1Q"Y_ |~d=+m<m/Vs,ZN}>:#ͷg0-oCpHg>f|`=j~ jy^³ [/xww$j5˺.W!m Yg|)}kgLаF"+{@?/أN>uxwUsȅ{&#Z^~ΞUgoNm} H`auP/o|WR_~uƶڛXLXQ#㟷 x㡷i=1.ZI6T~&=E{N4e\8[ A¶>$kg?:ֹ9IX! r+ȿ`φ#E;'e<ЫczQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE?<;tbFݴ27 j>!|lGc|5P?]J/ kˤw9!p2}YxNb|2!^ΧђC bd FEg+iG»K_% Yr@g=z(bWI3DΖvD8$?:φO_Gh-F iO].W1"3pJzؿ]KI4^ !v BvO_rPN+ג E2Yxս۟XˍQ_' PՠRÿ[kRoX؁<) vӭ*X«hW7~h^.ΠVW\2A:l] (((((((((((((((((((((((((((iSU^i#?o[[ا⭥_ꊊ:m1~* >죤7v8|Nլuo&䳘Yju*F5 9oFav>!xK[eJ).0}hx ռ]wlEi\c,Iw_m /`!Ho,aB$G95|}|@]:z4[x!ǧ5K#P|A6_ x㘅VA.@h>2xG?gL|=Iai 9|9?(߂>xWb񍖫⨡^tH ;I V~x@х6ZJȪBFpGz6N1_ CH ǮmR'vG}x?3xWҡt[0bNϽx'Z?L/=ΔnM[) waYKB?Wu^7^Oػ᾽i'f p⽒ ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (7.~#|Si +vDA˱t ^ ׵(m,inn'p($~|~)G[A~2]˰3]%x{jX4[7JDN9#מ01ƞ&]DAwiiB0$8qYO:N򭿅~ͯs:]zU ԾZU9S%lYGeK_c)BuXdr:zPCY~5 jk]F9p!3nE|nwAR~~:Ŧ]ܽ¿[\;`YOB+D`NAW߲ᜟ"Y ͙s܏$osW~/^; 2's<[p X$#=)AE-QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE䟷|=P^M{׭]oW?fN+K^)?9E}5uD Mrݢ0U vւ`3}'_j IWvzo>x[, 9h6.s {sAA>!t kPK4>TD($#k(~ۃi]5N'񕚰1FZ)Wsc@nMVWVj?juŤX#bB \=Kh/'.%{AO%Փ倴}w~dzW_X'jROon&R澝3㇇>&° 5"Ѧ .f,EI#kW x6b|dҾ9k["-+ B?w-}k+G <}[R;CM*[[U8f((((((((((((((((((((((((((((((((((((((((((((((()fx=C-4GF,Ğ_]*O?᷁n4RLrK.i7((FH{xV|4-WŶx4s!J^p>|w #IďL ?Xn5y<8R03ր?X``#ET|۩Ծ,| qzi_F#X;I3p9L>5xx{O),XZhw E;1v@E{? XG!M'J\s]Eg<>+R֦t niU>O+kWEG> vtVv2PPgÞKeC/-kۼqd(|hD@t` U]>*x;P}6Ƌۘ5 6$Sz)Ö#m~ |/#;s3KFȺtHAv_W1O6|3~x.4jcu8?mx{^#jOEi4>Fq^[V kOSx'ǖ^M?uL%p10ڹP {Ʊ&۾!~<\?~,26.#nHhߌr@z}|c>6fI BNZ@sρG xÞ=O?tH#";IG9v>oq_TQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEW7:N ¿d/JhGs_łOj#Z=,!K~NR?̒wi Q?~3M->>2>E](9ߋ4 H.A_5s"G&n.k#?tauj꺖s/`hX '_N0L$jſ:?O>]Yh3ejH-B!' g_փj]xh5v\3&;NG}Wt$Q3 )a5qƒk7?i`o$̪? P# G~q^20\j7PXXa}-9B 2,1G ~.q|! Wnm[)d19.|BkxO>.Ε} پ7QSGiZs XP~?OoO>&'յD~Xdϗヌ@P:REPEP~?G^ounZFI-/466Fu3ҩԷ:L?jmxlj>4.jJ@QEVմ=cOK-h.!hEʲ_'Կg?ڇ_1j}G׆{h[W|W$z_~v|(ilOixGP0!+5Ͼ&*M}E"F# QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEK||?Z ٦7Rq¤'m}! Cc.|FiO>Qmi 7(r6k4{ !|GGTHyd!W]h|]>Pyy?mK' φS֟v*6A#+?M|UAis] m2 d n& =I~f_mb hs5Qh1^wV2;'k/޿?l ̸wI!1?`/P.l c/ibMf+d<[K|3~bZǶe#tnr ~2r;j|ߊx9q.(FѕFr:Wms_x;=o?>[;}Jzzw쯤MQ# ^x:jZ\/}?'Mbiqxľյ]eѮ01O|q ѵ٫~~^2MRZZhaBpyׅT?nMdž`|&D!t @L|#_oŪ'^(hN*G"u ~'4߇ujj,]~iu 3fW!~߉>j2k8M ;}H{)ey-Pܕ{K+q~?h]NọZuKmu{ dERk???,/Z}VQp V85&7|M,3Ût;$_#R@9=A0+?ۓK Eg|)Vݲ$]I\rM~~?¯O/mt;MHݠU1Xt` c [)ujշk2f?fII_,˽| mֺ1ck m1u]V^,rW,4U`Kjk3%bYȵhik|IO?N)vcHWsK_'! fga~SVv?Xsqe<im67}nǾ?iTr:fKޝٻ u >22=ߠo~ʞbFe$X6OGǯ'A"H \sn1u,Yi ֪ٯ|_լ_ssshy $mdN3ٻ}/.-)++ 2=֥.fW]dm]{L'Milo+-aaV/ϸ;kv'&׻UloofFF=F32>:HuzQTgFdeY{A<릗W=K,;wUYEŷdڟ]>Uݑel'(?h)Dz3XU:WFn5,7_okɻN3oѹs`vcULHЬ̰lqsA/u?c.ߧ_pks6\COjIJkM̯'$t77'&Gf;*C^NOL2+_k,I=<WW(Sh/QYfQUc,~VY[_[on}6AW꾏az.u>^1l ;Vِ.}s^>)Ӣr(")incuT+..)72^m#G;g[NS0e+sts1_"bnގ-+[[1Ρ9JYVڱl&$43$},=Q3jy5wdnm;w1s*+XL7֌דUn1c*DZǹ^3mv=ޫ죨+T#p̳}lIONNM77KMwzE[{cQGHpY2k%"WmmUWk޵Mn>V}0<>=mUnoQL ۝Ԯq6_KAQߍnҙkv8\ymMW뮦6+ƀkTSOV܆O7hm7!Oy-a^;2'y]RK+eK0q106e?MI"d3zv98U:j^)N<71km[ILf6Cy7/1V[6Q~w}f܇%JtKʵa ٶmv<-qQY1v^X1ck!fTqi_csM,k,y49;.^6;-v׳}JqI?22[7ʺMX5ez,`{gfnqj/!ǥۜ]rAqMo`[]9g_B?#?;"FF5?Yc~~_WNgNne*ݖr,-fݒJ{+ޒ_Ҩ-^~E&j,Wf?>oE2ۿ# ͨR ;kmuu=[VnS]l4i)Ǿl1;= G>Z赮}?B=6B[xi{Ə`~nI$na.nm՗1@e\8XXX݋shXs)%5e.Lvo+й7eX{~t>\i.cGOm캋fbVV&ebY{cCp/RJiݍ^ k}Gm c}kkֺ{wR{V;Xickm}hutTzӮGe\?g7zok=FzNgzv-ĔfndYcKr)0{cYQ8uh\!Q;W=諫hdnS#e}#ߔS 鹕깞}UzUS+K"Wuo6ʬik4kkVѓ]P9j _1Ic7wWFCa6z.$݉{Yg}-euڏ[gj\=;ݿ4UMcٍS^և4f>[G)%E~kg\El~ܰ:T}vc\lvll:约zUS7jqtSU:jx<{\e~Ծm3Ĕ4_)h59QEwջңXKK\ki$]q'YCH`:;wD uow#t^aΥս/s^-v;vs?tߝ{qsunV .cƪT61-lmnKS.kLX =IO1~vvkێAq:9K7Ӧ܏N?GoտGzOO2޳XlkuvT?Mo?zK\_n-/qέ-{[%G{%3kN45!o-%'$:sz>S~?\v궶9՗S]hk^1)X4*`vP9󱄇s,MkܒU{[2nk@6 =6ٌ)tg6TI_qqh$MuOj,J<Νӳz:P#!ݭ619[>66vѽF8zQ/{2ه:Swa}c$߿}nOo'o )1:*uuTOC=Jtkul쎋m7ر@*^WwWo_Z+l3K \mg\@q~力Nrӟ~F,ٳߥ^~P}uɝ~tXi VX6Aj }xŬ0'kߦ'~E8G:ea!m-nwC\v%{mRZ47k9%;N/5>]ׁcϭ์ﭯ-??5 #tz2/]i::}o_QbOab~MU}ދ]1{.et\>(ʾ+ǸTlsjԮQĔWzgEM\kO\7ss߳c%7:oځv>ltVOM?\Ml޲5q7{Ok\>:eUYhmoifYe~Ԕ-;H:+} 83^puɝ>u>uqN6u1PgYw1Gw=YfY)nJ63k_a]fuo#~i9nD˽+kJ{ AX^Ê;[鱖z;ZԳs7[z=r??Yޠ:'Y0C=! [ޗ }~󿘒}\mckk6{juW;ӡAKcP[v3כ/kaYooZ_a]OwVkea` 56z5ϭTʩ$ꤗʩ$ꤗʩ$ꤗʩ$ꤗʩ$ꤗʩ$ꤗʩ$ꤗʩ$ꤗʩ$ꤗʩ$Photoshop 3.08BIM%8BIMXX8BIM&?8BIM 8BIM8BIM 8BIM' 8BIMH/fflff/ff2Z5-8BIMp8BIM@@8BIM8BIMYlPain Scale GraphiclnullboundsObjcRct1Top longLeftlongBtomlonglRghtlongslicesVlLsObjcslicesliceIDlonggroupIDlongoriginenum ESliceOrigin autoGeneratedTypeenum ESliceTypeImg boundsObjcRct1Top longLeftlongBtomlonglRghtlongurlTEXTnullTEXTMsgeTEXTaltTagTEXTcellTextIsHTMLboolcellTextTEXT horzAlignenumESliceHorzAligndefault vertAlignenumESliceVertAligndefault bgColorTypeenumESliceBGColorTypeNone topOutsetlong leftOutsetlong bottomOutsetlong rightOutsetlong8BIM( ?8BIM8BIM AyJFIFHH Adobe_CMAdobed            A" ?   3!1AQa"q2B#$Rb34rC%Scs5&DTdE£t6UeuF'Vfv7GWgw5!1AQaq"2B#R3$brCScs4%&5DTdEU6teuFVfv'7GWgw ?qEu_l}CemK=ݱqeF,99d1;]476?Mn?zX/s4bR*OfO7VgQSmu]Z7Yc}W]zYL}X~S|kr/Se]SnF 5ʯ!5QWҲ~,e7~Ƴ.c4osU>Xt` c [)ujշk2f?fII_,˽| mֺ1ck m1u]V^,rW,4U`Kjk3%bYȵhik|IO?N)vcHWsK_'! fga~SVv?Xsqe<im67}nǾ?iTr:fKޝٻ u >22=ߠo~ʞbFe$X6OGǯ'A"H \sn1u,Yi ֪ٯ|_լ_ssshy $mdN3ٻ}/.-)++ 2=֥.fW]dm]{L'Milo+-aaV/ϸ;kv'&׻UloofFF=F32>:HuzQTgFdeY{A<릗W=K,;wUYEŷdڟ]>Uݑel'(?h)Dz3XU:WFn5,7_okɻN3oѹs`vcULHЬ̰lqsA/u?c.ߧ_pks6\COjIJkM̯'$t77'&Gf;*C^NOL2+_k,I=<WW(Sh/QYfQUc,~VY[_[on}6AW꾏az.u>^1l ;Vِ.}s^>)Ӣr(")incuT+..)72^m#G;g[NS0e+sts1_"bnގ-+[[1Ρ9JYVڱl&$43$},=Q3jy5wdnm;w1s*+XL7֌דUn1c*DZǹ^3mv=ޫ죨+T#p̳}lIONNM77KMwzE[{cQGHpY2k%"WmmUWk޵Mn>V}0<>=mUnoQL ۝Ԯq6_KAQߍnҙkv8\ymMW뮦6+ƀkTSOV܆O7hm7!Oy-a^;2'y]RK+eK0q106e?MI"d3zv98U:j^)N<71km[ILf6Cy7/1V[6Q~w}f܇%JtKʵa ٶmv<-qQY1v^X1ck!fTqi_csM,k,y49;.^6;-v׳}JqI?22[7ʺMX5ez,`{gfnqj/!ǥۜ]rAqMo`[]9g_B?#?;"FF5?Yc~~_WNgNne*ݖr,-fݒJ{+ޒ_Ҩ-^~E&j,Wf?>oE2ۿ# ͨR ;kmuu=[VnS]l4i)Ǿl1;= G>Z赮}?B=6B[xi{Ə`~nI$na.nm՗1@e\8XXX݋shXs)%5e.Lvo+й7eX{~t>\i.cGOm캋fbVV&ebY{cCp/RJiݍ^ k}Gm c}kkֺ{wR{V;Xickm}hutTzӮGe\?g7zok=FzNgzv-ĔfndYcKr)0{cYQ8uh\!Q;W=諫hdnS#e}#ߔS 鹕깞}UzUS+K"Wuo6ʬik4kkVѓ]P9j _1Ic7wWFCa6z.$݉{Yg}-euڏ[gj\=;ݿ4UMcٍS^և4f>[G)%E~kg\El~ܰ:T}vc\lvll:约zUS7jqtSU:jx<{\e~Ծm3Ĕ4_)h59QEwջңXKK\ki$]q'YCH`:;wD uow#t^aΥս/s^-v;vs?tߝ{qsunV .cƪT61-lmnKS.kLX =IO1~vvkێAq:9K7Ӧ܏N?GoտGzOO2޳XlkuvT?Mo?zK\_n-/qέ-{[%G{%3kN45!o-%'$:sz>S~?\v궶9՗S]hk^1)X4*`vP9󱄇s,MkܒU{[2nk@6 =6ٌ)tg6TI_qqh$MuOj,J<Νӳz:P#!ݭ619[>66vѽF8zQ/{2ه:Swa}c$߿}nOo'o )1:*uuTOC=Jtkul쎋m7ر@*^WwWo_Z+l3K \mg\@q~力Nrӟ~F,ٳߥ^~P}uɝ~tXi VX6Aj }xŬ0'kߦ'~E8G:ea!m-nwC\v%{mRZ47k9%;N/5>]ׁcϭ์ﭯ-??5 #tz2/]i::}o_QbOab~MU}ދ]1{.et\>(ʾ+ǸTlsjԮQĔWzgEM\kO\7ss߳c%7:oځv>ltVOM?\Ml޲5q7{Ok\>:eUYhmoifYe~Ԕ-;H:+} 83^puɝ>u>uqN6u1PgYw1Gw=YfY)nJ63k_a]fuo#~i9nD˽+kJ{ AX^Ê;[鱖z;ZԳs7[z=r??Yޠ:'Y0C=! [ޗ }~󿘒}\mckk6{juW;ӡAKcP[v3כ/kaYooZ_a]OwVkea` 56z5ϭTʩ$ꤗʩ$ꤗʩ$ꤗʩ$ꤗʩ$ꤗʩ$ꤗʩ$ꤗʩ$ꤗʩ$ꤗʩ$8BIM!UAdobe PhotoshopAdobe Photoshop CS48BIM/http://ns.adobe.com/xap/1.0/ XICC_PROFILE HLinomntrRGB XYZ  1acspMSFTIEC sRGB-HP cprtP3desclwtptbkptrXYZgXYZ,bXYZ@dmndTpdmddvuedLview$lumimeas $tech0 rTRC< gTRC< bTRC< textCopyright (c) 1998 Hewlett-Packard CompanydescsRGB IEC61966-2.1sRGB IEC61966-2.1XYZ QXYZ XYZ o8XYZ bXYZ $descIEC http://www.iec.chIEC http://www.iec.chdesc.IEC 61966-2.1 Default RGB colour space - sRGB.IEC 61966-2.1 Default RGB colour space - sRGBdesc,Reference Viewing Condition in IEC61966-2.1,Reference Viewing Condition in IEC61966-2.1view_. \XYZ L VPWmeassig CRT curv #(-27;@EJOTY^chmrw| %+28>ELRY`gnu| &/8AKT]gqz !-8COZfr~ -;HUcq~ +:IXgw'7HYj{+=Oat 2FZn  % : O d y  ' = T j " 9 Q i  * C \ u & @ Z t .Id %A^z &Ca~1Om&Ed#Cc'Ij4Vx&IlAe@e Ek*Qw;c*R{Gp@j>i  A l !!H!u!!!"'"U"""# #8#f###$$M$|$$% %8%h%%%&'&W&&&''I'z''( (?(q(())8)k))**5*h**++6+i++,,9,n,,- -A-v--..L.../$/Z///050l0011J1112*2c223 3F3334+4e4455M555676r667$7`7788P8899B999:6:t::;-;k;;<' >`>>?!?a??@#@d@@A)AjAAB0BrBBC:C}CDDGDDEEUEEF"FgFFG5G{GHHKHHIIcIIJ7J}JK KSKKL*LrLMMJMMN%NnNOOIOOP'PqPQQPQQR1R|RSS_SSTBTTU(UuUVV\VVWDWWX/X}XYYiYZZVZZ[E[[\5\\]']x]^^l^__a_``W``aOaabIbbcCccd@dde=eef=ffg=ggh?hhiCiijHjjkOkklWlmm`mnnknooxop+ppq:qqrKrss]sttptu(uuv>vvwVwxxnxy*yyzFz{{c{|!||}A}~~b~#G k͂0WGrׇ;iΉ3dʋ0cʍ1fΏ6n֑?zM _ɖ4 uL$h՛BdҞ@iءG&vVǥ8nRĩ7u\ЭD-u`ֲK³8%yhYѹJº;.! zpg_XQKFAǿ=ȼ:ɹ8ʷ6˶5̵5͵6ζ7ϸ9к<Ѿ?DINU\dlvۀ܊ݖޢ)߯6DScs 2F[p(@Xr4Pm8Ww)KmC C     l  :  0@8!17P6`p59"23'i  !1A Q"0a278qB#@$Rb3v 4uPrt%5&'w`pCSsѢTe6Ff NJ5y2bMJ02' 9d$HF#3O@DF3D$@ nӿHYV)-4Ta30:lD\Ґp&0 W&&,CCf|r`eV,y4 hFxF2 Ma%rFpXY+x4iUЧr猬;:+:r-$Su@U- ʮ.()|6ac  [q 6 6dva&ZGӤ%ۚ@rNrC0$vf$)(3p#١13O`h@X0|\y&i HoC Q֞1̶sɉgJDjЪ"at &&A cE6 fJFvyؒROCqҦ21gceF.Ք]@<S23Lx]ܑsu` dP,)Xcc:&FfRYu`Rot'|2:"uW6#9Ds'ɐl|J."KrFܦg:N ,Yd64 L昡ú@Ŕ)hhIS# JK0 -I2HPcv5a$rX>E2>y)"iW ~K g.` b.th#ȔYIPeB4th .F(tYH*8 %AMtrMX UEy6( (Ⱥ" \;;UK7"d'P; GBJR{tEI&) T@(233SNdpXMqVSua>@8Az[[#!ap6PdXr,UԛI"c,+H`T o֧DcGjlS3QSq2f`"KA a6rYˁ#;CkeWeW6PӦlf1uPEg`D:.` 9^%|)ܸ>jgjGw%} C#U8J-*(p1аs(>Z0f@B957Y*`p:$ -**Hd#A!,+ر@O:<P[Z;@<>J{F00'|Z -N .I8:B\[dF'D,XGs$4 7c2sjk ;W:4rX9krfD9Y*qLFZ+- j3K&"d \&,`Ċ'N!jO:" (ܼ#h;)8vppm`R s@Z74yLMl0j0|[4I}X3 ,́ ͌HC R"@IE)֑LgD<=쑀T+jcE1;sLp\Uٽ 8(e77 6)$BU#fD΀RB?v"Q= LF{'hŋԕ>ZiCv 9l;C;Vזt+z[ <Ak*Hf-ʼn*D9MjX 6Wigfvȳ0rM[}Lp6;3X@#dWܶbH51 i#4ѱK,$* +1"3dܯ_K; :.>N6L7*茬""dϙ*gp8L`͍[ !>vwfRnA2 <:s.Є/܀9lrPG n U5iCkGRL`Mdgѥ3| ''@|>p|Oy8d>qzOcvE8$ɦALd\ΨRuFlE鴈H\ "*Hwzwf$DH0xi;БgtEraY4D5qtdu$9=I}p zaė. ;&!]jc凐g8݇2FL0 3% Vj?9JDnHP'Ip8bp}K3?4jtH&2w#YNplpU! Wрݤj4ג Fm2&4 :s Ĝ!Q5싆;9G fv*tbr"fGvm = \J; :#?= eHJZO`D;0,xB2# MHl,1s0.034IreHDOɡsEaAN,>JeDB%=1a tɌ@/&@R>#ɢ{+=Hkbk@W\ ac|'L, ٭K+= 6&II}BccD=0 N@gx#90$q91B+DLg"#N5)``dͼf8l @wF1#+><~R).,I?#XȻ`[7 *dsd~~K?1$/$Sk'0?'($.~U]GP~͹K?贱0mJ@pQ6 >!zvt/ $: ?>tDb'c',H< ,$ ^R<\m{㟟L 3戯0Y-NN.O XArX\ܖ+uD/vyAw(˃@iJb&R5|kR[f (bxr얦4x XprDž9.gMw}s,j!r4a3s~.^&m& 1hyK[&}ܑU"m:5SaM'˝qen/~)r;אXJ5exy5YI籠N^,v>,RIKn~:| 5<>{o>&P/dQeYCή&,ƀA["aBuq1vmi$ Ƅ(SnhEƜa@m!5/Q N6c o5>!6td9/SSOEN8=cjtg8qbS}ΖhnFjA]<$~XD""FveԊe9Ū):%];g??/t63;6ZYGL_EcKНhɚ^fxܷ{gd &QYFsm۷f;_-*B ~߶'=W fB.^.moٲq,M>)픲Id+X? B&֊R&Ҵ;^3Na8k͸ȵvjj9sN/Icrw^C#QX_N!גß-8 nE.okbhca❧[i̮\!-7vU~+tG{UMVKXvoۿoY/WފdXk-]Q%6Jk=$`Q|qa_E갩&C̝ͫxYSl`=ωЄ7e h ;^o"UR4o eKmY2c褡SȩsԤA@4˱4C͖xõ cY@I !*{X#rpJ_L("qC#I3{}TR,O >D])!}CMeX|nڽ31!RMgK\I'(c$neD4{RD$ff;=ewdxIUSzrPdb_ v"T+Y:-'i}6ң|;#`|yafbt|3?IX۷nޓKo4: T@'Y/rjsҀ}5,%q.Tȏ8{N48rWא t||_:9WKܵ Gƞf(yf7)7(ǮUa 7YԼ!l6tEμyWzy>rjI)#"#-2.z8E&3ޑoN|t|e-BqWvwk z6[$G):'UU:"̱߭fʝ\u4'Tݍj,.#>"2g3ɬ^VY 2n5Fh🌒WB!ECBgvB͒Dnzi"ZfO/3Sڹ-l+3g^llk?nVrX0z\6HKIV38t@tai{W_/Ag0.[{2H2;w;"쬘!2"R@lrchBŁ "3dNT]{CF;%Җm ~]q}1I: #㕇!1\;:Gv&Ww#z6!lr-ؠmj;K}))~%argnLyY8\ g6B>ȳK}!`j8cwYǁ_da6>0:raq!7i;}:؝~z&|-*&_;݂$ fq0`3»MK AEG&+ }}Rv/F@r5 !& ŷm;bXfa999cu?z_uЄJ7X &.tAp.:f-9" ͘YMpц{wSu:dlv3M2m^ܬk9PJuO2ق{!%y<[Mڌ&SkѳQlݜ .]+h.-qqm72Sz'%h'%)jv}B-X,sc%U(hw֍&j1r=8ڹ>EZb0ܨKrsvfrseCo,C^Ap!RhyZ{۪:*e\[(3woK-;ew]&Mvnջ;uvݻS~(η"9$`icEV3, ""EarKB[rn˶\l40{mZ/Qz" #F^l[kUӏcl}Ty!+ p5tn߼۸njpUr{7;3'%ڄ8ٜuGt߁mlk#A4nGy),FZ03XpFv~Ӓh}n?0%)tz=nG r11;'Ŏ)P?IU- UTdJҴbu4L]K)$|{qWwBWYbe4׻YU&*5~ 3!!G3>x$skx+N)l#]y .fƓ4t&H(+*~"effRS (KFqlZCWnGP\Rs@gB[y1$XD\f͍{!sAԗ27IDX,< $ d1iz+?C1۷nn۷u3-a:r<,rz8W1E9RWkU IX!qNi; +##``)$g†42 r)JRrݛsS8cPiw %kFLgx vn՗.صkN+6Y)x-YfX=Vٷ(RJ\_:vۿoZҕ)ZҔInL3P!uqva䖭iFk3-V[6mvaunmGv'6.cѠi c"UkqYx#ZV]HT6o X}XVɎ9Qe$jWq,>r>@02;~y=_"Bj.3SC1/Xxx 3e38[/9t7h}ʪi) !(N{{ 11iwps[m ='8?Ա2xLoDh.{HG$ R6l7yM;B7# R. |9vdB;8egTSt8 |%X#,y$2l=!#ZR05#p6t.erƜQdoaG+bWs} XǨvݽx 1$[_krtQLMO!0smdXXR |rlhSP)&ǃ;O.ZC~bɉ8Nvږ8Եo%+Kuϳ 8]NJƖZRtm"qR RMp9=]%ZL< %َ'Y}02#`/ B&|+)K)"Z容ivNS ƼTGQs]P-RE:]nGcFvn+d;~㺸jFMP8:8v0YgQ]M |bv2,`:-S se0T.\YoJ!ycCn8"H Q?zͬEA㐢9 Jz7zVPơvppqEெIJvG'"¾tO4B.&5<_=VDsMO/#6yHA,^MJ/i8r']HD~Ϧ2U /vـa&r~h/ۼ"J#ԏnM9"SF T0~5Gy7^Vyz &ܫ Ua&r~d1#+#čNM9"KF)ԨT1H~5Gy7^#-#$S7\\jn959N݌{lbbُnoƻz.6F,5 8XxmbXg}\l}ёrW1q޻~fL,< 6q\.65o#~0YcφK讒2VfזMJ;#Z;/v;HlV(ZT!1P 5\ D)-`ufyg(A;%.W&%V`?U-1P7ψsdZI"^.c)e 8^'OHw~u7H^9 7Hhźގ$ItlzCFA1nBq8#IDp\P:Cu&>?sl`h I:P8XrNq3j9nKd&bPԔ' >d&g _ad9`LQ+K6ZKP"-ƴxVmdQJRs73C Cq;*%YCi3 BVDkI|^!pC4^DΩ܆Q6*DU͌r *3n(+&M&c@UE.xYhJ(kS*<>g & Rl-"*lOD@M1,aˑ^>fU0Rfg@#4}sǨ.$q]!Pܽd:u%k)O '%AJm%r*-Q[." q-.\vPmlM'qbD:WCD5,u@OE5 b١3hȆLAXڗ$6Fz7X e-@rD4#>d !&&D&qɆ@rkRp)"S`D&7ddF/14!Vb;."X}b'&5?Ҵ+~mmzִZWխ)O~>֕)۪֔W粵<m?Rlʌm |!EͷjTF:ٞocˈ˖}.ezlјff)G-$. ǡ^Z 6"RyU1%?8<+Y6[ bj9)#)g07m &Ks,Re_LbdɃ=VeiC,̙Oo KAm(;%xc8eThǑ5 7݇P|Z޲v>%XGANT۝NOWU!;Ȍ%JX9o>ֵ/(q5\DvDNV X$(B;^X'f .^y;J 8U\9٬x [C)n[zY«YE}ςn5ۨK1;5 )I9L%}!{x퍿{eZn5'ukJo]ۻxwn+]M][zZV=kO|km+JvniJ7o۷_T|) 7nV6T]L"#>KW|~'#D6ۖm<EF=OxZm5Uِ5uۺrO|!)x+aXaT۴}I~0//~֛fLMԯcWy.V|S:d[per92lZI]]kOI8 V6,ҿ Z:ԁssJ?wy} ۦiج"="\YLԧ<A. q5 ^ [\(TtOMf쥮WZR5] BQ7R<_$62+#)O -r!gC'RI]oƿz NBcek}H0hqUi_wۓ5bv%%Gk  |TB68LZQ-CEyf۞%+F!6E~w+| UǥqWr]2-)M|S緖5ih)JH~JR+Z<?L%ҳIv[??4 e ?s?Nf?KIWgٿMO/?)h?lwR8쇃 .\YsF2ux'_w}2ux'_wH[&iA7L:d񓯻N:d񓯻NKFH)?x'_w}2ux'_w}2uNn5Oj_S8v8d񓯻N:d񓯻N:|6Tm7l}2ux'_w}2ux'_wNx/BmCw}2ux'_w}2ux'T]H)yDkưg'_w}2ux'_w}2uxѫ`J\wWG'_w}2ux'_w}2u^o5ߕ Еg =n}2ux'_w}2ux'_wdlȲ;9̳1d񓯻N:d񓯻N:_dQv}$Yaק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק^Jzy+uק\O 9?"w?"w?ồ[$VVf>nТ i6"nt.X"u ~"ܴ `Ē׹S/I>fj͊)7jaԪ|ıs4,kɥ6Ra.Ԇ֠TJPzL*X9 [ hP$){&iCQI uWToXjgL]ߐCi(Ye BXx6{u&v gVt)J4uG_apĩ R ]"]*گ)N˼;)0S/\Y*t1{G]x^ð}W xMsp[R) RMx 㧢(cƥA6(?|J{5زRAP^A>-r%j,vBj@l\LvBnnMn3'oDN9m1tjD(p9Jm5OvA~5NB ):"]I|{Bp*Sp<éM^8-m.LZ-H*J G_ۦ_Qz"Zo.?`Q)V{toa.E7Kc[,KOvأOr[mi;25)Y'[B@܉+NZvw꧕.&۞JC VQ)פ}.e`&,^&YqAsէ4lY_yéVŕ'h=Rk9ǝnB7K;kKPBS2`qh!.IX%OZqP*;zSb5ԕ@=Di\0wsJ6H [Txp q4>]D:cdʟRIޡoꖩDB%B%T$ E*˯V R\,67(!@);Mjb[Gq#8fL7Kf;4s27|͟\Urbo[R}E}w5e1ظݩ0b҄$% )] z,ZJ$~$r.(έkSۦ>mלVd J4ڥ|:44VrZZ,6[.B**e.. Guu2|.EgZT(Ul<HKPA~%j̯ɗHe-8lӗӮ 7'i;Hӷ;/A5A$ wKtF}R&Æ t"=?oLm;\VvK ymT5*O.Z2 sWKkJv(R~~FQ"b֢J{}f{{jTN6"|m}[e x8SN5lzŞke %C M6䷹ )%U:L[p->sklJ*t3b2P* -6ؠ#]+#wKа\fO[S+Eq}y*bԓPԄW$i֘ a2eTJ@%1,o^ހV Ew Zy%kR+Sw3nݭK+r "Xm^00m*Kp5Ep)ZԤ˛9 i"S j)OQ"\9HKfZOx?QȹU3PnWCMt!G^%仌. '0Dx2q%HJR8{MqrBkKFU4y @=ډ%ˊnP8Sr\hJǰPVN!burnp-c)㼦[bnVCͅT) F3'aiWiF䆘uƁ@5)\!@2Vg6qˤ{+(Ji!!ȀڥLX.vsw"&/QUVM2BBORT2pL,*SKMXJ)YqCjP!g)J JA*Q4Ny[ZdזK_c足!f*ѽm8RNC#H\ԼדTerISnPe@kR7 ^߯5V2,K6{C fzv#$:QBʵh|qCXՆEZđr K1QO`AYK8ؤ-Cq6G#ȹiR&ؒLhYφ!uJ  ~KeoXynqTPDKP}QQG166$VJٕ6’*md;wR{uy2o/,PG\6d. 4ս% GJgsa6K˩ CZ JAJwkE+}!+{e8ԤO`9#yx^Zq+ I[N]Rwhq*'] 0)"i,1VkLtE(!m|GMV'ק\f1o rD.%BAR$tΣ[}q4qI>ozn_-s­OjS *ROgyoPV+~| e!"uIO@+ۥ0ܪєlLJ *,ԤҾEkvJBYM%ߔƧp+xDL` S8>hԤ\WVZldXDہmO+ӷ<=*np jS;)N1%%PR|"sM"\T+JҥGir;vSN6v-$![HJR(R(qK̼YX JBЂ;A"ݫkiLKKh>-AYݴR+̼4|aADy[L4ZmN|xqݡT$ߠU*AzS\d .ekaU8۫|.C(nM$JBAKn 0 fE RnyNEJAZv|C}4RXhQA^WgaU:+`)E']EҌbʛkjȷqأ ^=ZCC*ۭ)*EAWq 'Pl*efl@(RS.rf@rCY!P*-X aSnD‡el<нfa0_}Jp*ZÒCmJl;Kji*>Pun+L\FK=NréCBvSe(P}zf2"kv8h$ JzvFH"lM)2 ޛPڔ^uU`Ԋic+_9rLt\ jfy1QX1^!<."2a[KK*eġl)R}V/DXL4jJJA%J'KugjIRT?3xF"UzT+JS~2i;mm @>va<}˔SMQڠONpWCu %hu!ĨONijaJ4q.I#ԛ{t4)sm RTb#1YrCОj:*T{{ߏ3;6iljUh(v<9C*dFC%X!)qj9B<{Զ]fkaUgt%I*RR 0+^s3g|Ż-*ӭ!NEP:z'e([-Ĵ(*Gn7|2LN/) W$O[Uu| Kp(ڥP ,Coөv? @F3iVVB V%BP#q3.@.{ej{qib:bmqw+TimZ* R%*3܃7n /Ā"'E2*(j5q'*"-7)=MCוK ƿ_r5T)>{f۲%E($uҺ:#EB[hly72#uI寓eWn~ 1[ P/):vK0m1J%ŞI/38mzm=T'-=. Q=;; 6(Km vPۢwٰ^fxm(RHZmЗRI&gՐܹ5[n[EBh5 De,Ga;Zi=g& v"uźXRT=ZZe6s $KEf5=OG{}ؾ\-]GED!xIl/!l|E;Hp(H$~ds.m6Ӟ%%[^qTBR B>wZ yu֘:3L&- \\w N=tM:e|/=ݮȖ%f͐ HڄesNVl13Gmx% :3BOVUܭ\yzm=޹wxin7 j;+V럘'<-mxLqSWSAخN?~p~ChjZh͞׻VcX(J`? q˅eы&>)qk "d4N@ H,w+T&e6 ɞu$WqoY~UrEǢ;:pp)AIZձJQ  5>r±jݛ]oݣħWP;T6Ӯ9ݷ.%ivʌ,a63ZV@.m)FZ [13HO_d vX(Cx^MZg٭#Ϸjl)HFqIRIXs:r3O]V d9OƣHHZ*^8+y]oo[ ʒOa@S>Bu~TWG,ݸ6z ط3J(R&;H=;RRDtYNInDxL; $RӴymǸym* xvdeR턟 &'ֽt#lw ?(2W*ַ椘ti KeJ~RBeK^:niu9l,:qǾZ,/p- y9km-VGEM;Nhh9^Ang[r!%Gq⇄ʹRBO`#i&\(ϱ'ж_,8JPLFǛ jiZzqv&SmgsK\t2WP\[{*pJgܣJp*)n[Q`b*VeE\:nPɘ- Cbt>\Z[umIhVrAZmSqu0YvviS%n'eהG,yS6M}E#Y:D,پDB{ 21ƕ&RWX|#Hu71-Uн((ۅr5:Í37l^QsN \nT5׈rgXe?Z'7'gmk/)@;u^/d1k,Ȁi!-4 RF٬7,ٽMXf7IrV_I;/N72}l NmQDh*QTiR RZS{wmgzv1̑ߐlk9 !kCݶ*NRynTydLZ}m2ͱ5SQ21{+wOf eq)_zHi}[Qڀ:p?1X-e]$%D?ԴN^b]/"X|y ꟰MҴ tSX~S\|a遀,wё53q2azV/­~c8-ǜjbx}mۋf9v+B[AmtMa-\y0iR)-p) G?g}m^6촹;ϬO=ǩy'ލ܆PNPz={uomrZ_wj$`Own!%%f4R i6Aī\ٛ;9s͢=4D<|ɑVp9ߎY#OFr&=iyf{2T$KM7-6ǭu.s_[,p.C#L2E*APC"'f _9iư5"-L-!xK*Z7PӦ`6s,9?0@xr"D(i) Uʯv̦],J]yӷ\/k-E4TMj)H$н\jVoܢa3̸&zUs-E.# 7"CKJ "EHeiL[N4{a=+gWW宼a/Ehl)k]]]d6(k-`P@=Aם M[izCmI=;ZevUa\JJhe($֝Ԯ [%;kCHÿHU %\4IIsxIh Z3 ޞ"_͹9*< ZĎ5yE2l&v!NK乱a==!%E}*IRAҺ;ӲLw#X.A-Ef3Hsc.8]ZBMdFSmcL#%QJ(GCW)15mmIhǡ6T}sc{ Rhzk([B $$]:yXuKIy4E,]CtYOrA8I2Lk*zGx 'p[@+i5[KJVX"Y/GseV+q S ֥*˨6nfYF YP* Q4S4p40]j-M )KYCM8;uŭ/\C5[K.W| mJӠV{2YоܣMmk~⛑R6'p5|1XxPs]#m })i$u~]J sqGCew\E\*X<[QKra aI <œdžkm? "b`.mFxA.tt"S|X BZ,oTAwM)))`t̸s#8ͥT,mH[1RON\yh̅)&r~g}خ8ЅJ j:SY0&lg"GeuV.1J;u苸p C=L;J6(%Zq<5!I)XMr +yG'wOopJz[=a-%M;c>+W,?MeJv4|-m%Z)]pi{ާm}@S zk"Ha<5SZ;Sm)q=`M:u=?/XscJ|kIӴv/0sʥ5*wzc߲^ۍO%O!`5*#Rd71։.NP 45qn!)kg};5rCSC.7- q*@JOSF-ջ1ڥnf;:>"׹|uig9ۺ3fƭKM0-pkoOvs0#\u!$Mmp$V@! u=1S 6@*H= "(U3m3X G}rLkÎt'hwIuM~4+b[(RöXND=)ڪ5B#S1F33As* n@ukʱKW~d.L:ҫE%B O'3n[q4Bm%K'V߅c9({vK̤P/2·{B7VEdQ!-Z)Hv/z}yd f3?6X]QnNJJ]Rx鈼7?̠xoSyN8VPSOVfhbb,2m9!JR֥N6:xO JqL*ORFY2W[l"P PB:zy2^o߲l& !i"&6#BW4z< 2m! @.6 ׸!GkN'F?\ \* m= ՟wȳk#wOy;RdL R4{{4TU$wRVAyҁE%7;i J-ހ$=Hqy[0:v%فkPU@IRiҾr-gHq%*=``KAqp YS y)HO6eEWP|/)n9 qL!‡RZ$4XBAQK1HCmD% N!+yNT4sLE)G{5b!;Sjņ %: 6rU ?=?n*왍M#Ǎm(+dmPv(zX5۹ҧ`!ꚻ[Yhmiv$.5cMٯɐU ≲kTbTԷ֕W:r{DZX]h)5566L)!jg^) mf:Vh0 OJ '^`u⑙r>C -juM"Sr))# AX)?$LJ}v 6f#z&>Wyr<4 P3;Fꊄ]#˷Wj;qyö KvEBI|\&g*űG~5Sڥ,<CH)JN Zy$"+-҅t :T8S;ypra,Mw6Of;i T`<a\ y RCl ;GUX,'xWOV0xL]f=&irRqoVA#C3 D~D.0,)^KBPU#,q^.R]m7'{eBD2n2{Dowe iҤ^;ۼYREҟ50 rl,敷2vu$I <{ŧb^J|ɸORWB Hnͺ(w nQa|HRZ$j*`-͆"@1N¯ )&>"Ma ۝.+7'zݲ5\.+p[ABR!g2b$-˴\US Ĕ. -ޠ/-P'_]%"\HH܂|7:f,V:x$!Ё)JR@yBDZ<,~"K$i&:imI}iE]dc?e1ԥ]=;OmnXl-h{7){ KLWKJܘ. /&4OxcȹZa\IaVғZ) ZII4#WYZ#bh][.ިV~K-§.:AYX>qǶoXt۵\q6G"g}&GvDFG9Ny1؃fGTq6د@ cYMqrJE1kZ5$O_G?[[Li#irF!!@AŊK|ջ<%rrrJj"|TJPڨ DD7e$.4=@!^*mNUOR Gofj rddc4Dko⾛{ P{ƬPr_pQlν4ԙ-+ z4䛈mT ކ'j}"zin (nUMǻжe*S-2ۇÊgϑfH>jTz +I>z2N?g­R.씥J TWVVFX5]@X>/B$T6iؓz%aIܒꤏ| mc%WJ@%iRn neŏi'[0-Q @(Bz:$|7k>IbBd+T_ GB?nѴ XIrd? *] >~yOM4NF)JKjn*AҐ41e3~sI̤hKyj,R GDu]1F};^BдPFBmKQJZv+nͥL]-3!SuHZbq=i)ܟ< /\v\K|G$T !}~.Ete0(ݮHOOBFSY,-<ȖVV֣\r۝civ,P,dŗs<%+Y$P sgOo_n%έ[lb,(OdD6<(qd;(sl! ٹjAHG]40'yXn!բv6#NĨo{-SȮ4ɡm64M&0p{!9C̏mT؏ުM59 @%RZ~ʲ7F6fv<F-2Y$wV1b c uLnBq2u3MD|:ъ#> 2,YTfNՀ)*4&-!p^Xm%<䥳:S4v/a%Ea** 7}iL7($MW^@P{Mb $q-$VQiR2.P#H#Swﯨ }*Zw;}>X:MCz,o0/((*}w |}0^'[#”UK'?0Xӌ!*5(Sl~Ҕ+Rjr08݇ {M% lvtoRBVx؎ 1>T9!k|OgIߖ~igs+])JHQ5 #0urzh@i JAhoK|Pk٧۱p`d\_RR"PA?ˤ#//y3.9-[T6+\j.`|u;.AʙX~4oKkBJǢ;rGa! rʔhIyT8EỀ?[\\eQ.mb%:#X%Vd\4Ai1J e(X V+𕱈ТL%6UoUo*4fRJ,<:Cv-bcs8xl[2,>1vR-JB[J:U= Nfg6wO4T ARTq|#{JiyɫrR\p\ڤ zSNs**%+3^ Dj(Chquqe)jzjklN[ļk$6ym=<*SOթN6̡Fe%HCM":sr*~1yc\iv%A!IAv(^c<uW=ũ[l!4=Ek@+%B@BW]'Lze| 0#7nymoQJG⦛wfp7[zJZ+k%yR .*e@relJBn$hRT!I$G]]yG.ǕHr>Zݔڔ)ᲀT5Z3,:z`?c;#qBJҕ:vhʊTk3&3-)l26TЭJQ'Hf;(aM%)HŦrd(BdBa≩*ރS^t=5qJ :_pV\;zB,ulfFiE+u3/Gi ֫RE z]͢cۜ,jڐTM =ڻ˿ /,K!l ,UGfo(X3Qf8,HiThrB|J~6ޭR;+%r@u>켲pB>Λf$!(BEG5'Enc7{$i%tq%(R{x-qʖd\ vT ?~Rndg0\I"l*.U{A_3x9ߐWr'c[Y_Ң%(K˛zWȰ9` =mj嵐iP{-t0͜idx%D WnDg!FiAhP=*k=͘c^qJEA;R 5(ÑT0_$ݞoRmU{JqeNq(%=T@,6$nKzMj|7ifҖ!"Q4j |al[D8EHDX,Į4Hq@҅'c3<;u 8cݐꑹD$'.fejfaGv4orJBWO^82yv ؒtRn;l2&B.{]P]hJSL1Ѳ2QOoh>/!VZn8yH66\)D <[_eɐKJ[ J״Of%Hid,62RCZWVt*V v cO4B.'sdpO4 Փ ĭZv(Nj[BP\P7/mM;8g8qkZTGڝӮjf8e IH!T'Oq([.fQ׬zLOquSZTD1Qs`<ɝ0_ihIIݩ^iЃu+몑PgQ6 !-) 0;h URIHR]i@+KwMMD}8loyP)i-Du3aی U]bhg6waƝEJIzi Ci BG`E 4Ov]J?5Zu铔mASRHI$i-~Nj8h[4e8Ȃd\h,eiN9'+ɒ?q\pUXl{##Ka1IK:)')*_1]{pkp%1Z{vi/;g>[!\(]t)Ѧ>z|O1I͔ȵΜ\hԡ:!e(/^2sѸ&+gnY& %9m{pkF[\EcHQ:]4xU&_w7x(\C7;sؕu9hu>ۊzTKLCt6|N3ΜCqsP;)SDq#+ZFU"@/#w!A4Whj{)zMGmMGj#dKf ^-h:v? ̧oT=\'`827h[m8\ M(yI @;$PFȲ ry7v$Jʮ!J JLGMPOHi%HKm pĹ bhr,B[u*BRG4QBg~RyPdpu{x֞NΑ(,8P5s _xEdegjfQ >ʈq5<ܸתnCQꞽ4$C1l(qҟ"(@Siw~KC *[VۄIm/,Pd;lP֤_V/wk)a/Rz4b*FE{5}L*[9ȘRۏC/xu)vӮcZ2, !2.iaN H% "lK;iڹgʞ%݈B+riQ9c:tıJz\ %O,X-ҏy^('ٰcݽ=߷M-q#dq~ )GeTIfR($>9qs|ǖXڶ.+Z)gmS+fku(Hi=ǻFN̉cg-R~ZW#mEsEA]xb碤Z-Qa'msP\JіDECfchURT:8a\oxkl6[H[Rw>͓yZn Fj;ej m@H~~Y2Wi].@P=UxٚMNͶ{ iUz.>X]NǑg Ӣ(E~h'ʲ6D'2u+m`C $tVԂMh5wq.S\9ei*XcJc'^Гӥ{*㙍C[K\y ܂8$I4'\;MْICu@ *#ewbdY-NJ"c[/FZ \բ1nu4%[ Zm嫵@HO@hKFP?}œ꒖?%Q]@mJ 5M9&[ŎTZӬ:9LSҽCjQ?ӯ>EHRI?ʭ+-y5%ڲAk(}T RinaQ\|nnO\y([lmpn0y`g!e˂4Ҝj.@|:ݼ$n]pb";dRl9$)}e MSIGaCXbmk7mHI*i'yqK4yZ'j?X7װu~ ^}[$urwyo lj3nEȑqؐ^kJTBA;jjرoOC}JVӅ+'jhE5r>UFW8/֩;.,(l > &է2f0`2CBIM{7H,^sbd3nJ(ᴶVD۪YI;+9]ʰJ?:"یJoygx[JM;p^Vo_cmV.(T- jѐ:v#58&PnvF! ۑpeR QfX':aشk۝S)a•U>e:f+2M'h2 IE<$/ޝH]9Ŧꢻk4|DmRA=:ҝז~>tp壔0M]mڒA<”p1[Vv'\#",fq2FoʗAMT:.RSLՖ-ʘ@* 5AOd7[\XV=mNSnpm=ZƼiq2$qn?`n=/(C q̳Sr!9>m`ι0[cj@(aԞxnna:GX%ӆ/F&:ۊSe9|]0ׂ!dݽ:\|Ln[i{S/-KrD?xSPTSbI'c,6YFL4\e66O@_򑇵8*5&CmRm+DJg]y$O c4 8qݟkef x) :s_\3Ҹؗ;.s-Q/  *'w~yg;6c:~2nK n(* fAΆ=yp3NXȊěp3N-niBaĞlm;O1[ih e"!TRU{5rur,z7f717fِ\X|מxgw>>3LښyqU-̅9xjZʒ|4I:|֫k1r\Ɇ  W2!nB܆Z*JA\g'\όoqڝ1/B[ؖ*O𐾛γ>|WymF[le3[jq }ނRJuow"OqL!8%n-)H*9*Od5Iէ>ϥGnϰ֞uؾkv%^bYcK-dt V焅 jq3vTr=<MIJj )unmyWI?Č=gNLؠF#1,qWNzm7IVٖ%oM^ajVl 亀0:z˰'>K=J1|ӊ|SuxwȖ绽-l{a*<: _KN=/#p4|ZA-梹 %,7R^q_-v_erv]LZbK+9_ZjP^Q:"߰I>GDOAK)+Ei';U52(u 2bJX:+KPs\0oU+:/P';=0ݴc9L\aOu"W-%!ٯ1/ycs'B8Yy<7Z\h&?ht Ⱞ<{qh6bň. H=Ck+XǮ؍p%̚w1=(Nu^,X>Nk#HP}L{-UjB668l⑱,ns) 5VkRA%MP1Zӂ?䇛f<܆Iijq)Vev x,,nX \`o2JRN=_SN/ ۞UdqGy4u}Ǒc^ng\a5d´\-Ym/}燿Y|$iMpKF Bs8_I/^q(c}ˋDy{Z:XڴT=p(q2h\þ|I>4@t5sc9sY„خ32e"j(k[J(Jnm;ͦ#a}X\G#:2s[ ZJ U5g=C9ͮ7!w;,y R=a@A^1DO+푛-'"7 %]K]'g:}e6ﶒĆC8Q[nAT/0.H>w7K9c[!xjڳHkXάwS nxlYBL۔WX &3Bhdxd; h]b ndmXZcl_+%L6-$ )=*闟;%JAQZTi=ڕ12Nfkڀ)*)$T{ALx6 %mbn3U$4Sh]-0p$K = _[(B҇P@P=GH5$4Pw&3R *q ^MAGĩ,7!s.-&EB1ac;T H5 ۶NSN.ko\fh(H.K @+@=*"&-QTӵE .%&P:2) ؉% = ii-\ CrZCHe- BR;,hJv&I@OR4+ڤTr PԖAF0 $! ێiiR}z[qc5(hi @*=S ,v5R & }-PƵZeIN( IЪV&KI)jA@.%'%TIj5-!ԃ`"Wjɦ\~;O9[%Jm^*э>#3c$6H;TЍ#0,0[@'4idB8Gz'#iV m IZj uQŸVS"tT9[Ɏ0M;(OmHv;N>|ԀVQ4˯ictwM֒EA1btu$6PHڠFx1&a>f;L Qr֘RVIuzFXe?u(}GAH1k1n߇n6}!~W#DeSM \<ӞQn[JٻpPi_%X-8Q- {|6+^Yr)1 fZ}JiT)@kA ~I5v7A9Ǟm͸RԪ9x#LմD()HZT%@)*Qn65QcQ\nY%Yt%K)U=u9rfc!w f aBJS)]:ZCNqi%EMj[nĸAS$ĥ{NՀP4:m(-pKV=wSq(*Tv٫'8d28%-'2ͩnLKh6q]u@RR+m]ݣɓ%jnEzC@HOA=}+~6v!n!#2*KJZF;D8oOXm≁RHGwo#oC>G̮ȵ˥#6h)N)U)H%D:q]eK}o^puǤaҝ[(`TFn\Yd6^$LhCX./0:Bc@*WBǦ&;*3#lĔ6&V R/^qn$C-!%D6$%Ԑ(k+|zAJ=t2\TV\ hPoCRpVed+Wd[ǼIU>g7vvk&U' E6ٰ e2X*lNG]Nî#!\,]."8hrS)Pz(6=^VLnކ&Kr" ӻRȥpV 1pb%dxb{T;eX>~n۠ʹ[QRʜq*۠&IҺ,\KO\mO326a HRU)‰P"#$nnG؍P4ゟ|Ke*X5|,6BwTm{i ^BG\aY0]1D%j.--,) ;{(q}zrc38@6󭥷F A=5|1^X%ǝPNԐDb̛V[ws±Z2 |gERwIeKW)GRN~=s ;ljrh֘RI+7d/ Z+3o,ʶLfBIii$P9Y|qlŶU-8 >IRBHJA' K|S&3DM_dF~:h=%ԖJ4U ֣SCymsd[s$~Em:Z- 6T (A,&-2ފe(h;vy}hy%:-k* ju)HT@;~Nv5n=qDsL]arP[4;TTOJNǜ܌p)RJc-%% *'m:Ǚ^_:Yqd$v: h) (?Xr@sn&YJfInMsķ Oh cef_:6Xn1[ql0䕂% m(Dzs8ܵ+|k/eZC q!`^p*J"a\@-h32;QBOv%)CחHQG<eͥn1SNyey{n4'"l<V))zkW.F8Wk1¸ĸY{Bˌ((?W,e#xlE2 ;GR@#7c㭲T$! u6tkz_V4ʫ`?!dj7;5)nQ]ӷAK[V|{YTVItu_z%Z!I1;$sRR'""nd12=94e1 (z0\EqTN,ݫ6dk_ᐍ=w5u0ArTb6jHQ^z|N*ߗqK*±I+LNJ`hTK+ִ`F "dv_.B㓲»P{F/У^W, <'=4GX IZRҜZM曫41:՚`N\3$D-n))+}49x.(8^u]mw>NUeLCbh0Զ;7Ҽ+'*٭ 7Sv3sDZ҅)%7UPV\>rWpNc LL kYBTZ4wdž0{_!bQNE#-HZB*@^rMx ܂͍Y&vEL%7!U%҅Mg`iNHvmsrSXzK HQ'W^娞nQ֥Lb!0K]-u5ךy<Ŷ,X wFCq,!A¤О_1ѷC̆0̫MV{26z"CO"H;7mZ\Oϑh!IPKPGBqqU$Ax&! UCՙmc'T'sQ7o_vo4%u5ؖj"ȳҚzUZ6qZ׸]i2 ?|]'o0,NA~/8 <䷚Ʉ*I% }Ҫ5{7,-:wZe AZqOK 7TK A&d -xq;Zʉ P`a830 1x]U`b:]yD}R}ޚʜXɈDȰ]ںkKIx~R+L)4KVsbbwqqrSGP`6 vcJ l/)ҵKz\SCKr(9s M2#{χpei9׆-|.-9[;{HW )x)SZmu@ʱqt z)Qk(S2Y[Ym!.%Ğ:]w7m:T$G}KI*mYJCgJDcpVNG*51>c,KKl?u~Y3/^{Y|, KEd:~'W7Shͦ^mqZI} JJBqQN)B\F;S+.DAR @bBhlS7Ar8C3G@QJW~QJYLX%%d^e!xzO~WmȐ]c{ÑCJ]#"&e@dœˌTө(Z=Dyh8'ñ{8P.-O)-Hqcw,pbXUȐF\.ضx7P;~pm8(L!ejbJP:iql1ax6 ; VЛd\b% nmI[iMRjJUPK͗휋&-2~5Eшl$}@ qe/ZN [ d#VZy#IoZTO?7/ymmp9@]a,Ap6%Ao$cqmnj26cp&4M!U<3. AKߏ'f7og߆dmrrϳ[l* }REA~ފ~MZ1Ͳ3'3qzj3f8-2cZhEt( 1g:$fVǘ6!ąChϳOt)֢YWAhr'*[h6LIKi}+߬ \t^Z*! b5ܽ=wV:!͒3FoxpUvᄂyWB{+̯ cE>EG[)pBՂ;+uy/y8+LΓLCCh T^\g:6ifh±R]8gi߮EYy\S.T=4/5T ;^Κ_12f-pquͰ`+ت܀K B /g& orW=۶uuNȯl|-s>>ZZ[ֲ(u.(6' urqs1)FW#2[h:⒕(JFД M5e>j'ϔŏpT%([֋AĮJJ0ӑYjmn79ThV\WepxԹ 1Q&1DxKڳڥoj-ÜrV,4r*JA=J*mncWyccDXE S1*nW^ҹ< aqܴ KB۫,f䴒=)6|Wpr͞\2nC!gi+B9̬Rs-,͏";ҖA|=z]Z*.FfD8YxA qbRGgYV'Hܝ36VBوJ~,dSAqQWR:יf XJq٪e [?7w^첥˾6AG㯥>!j}h9W!e1"Ԇ|q+) Fevdbt |X )H Ei^)Ӳ כW8($JpT=ʆT (eN䙛;W~սM%w' >}J!!2)TuEybgL\B2}DMaUDdyT>iτ6+D\f’7-_ivmi93vrCrX{ lnojPI\3s+y9>v![ӯŤ*f |#y۶W ƁhacFér;]u$90=nqqAsbB\u$).2á”of~OV]oRxFs4җUWAZ0,Y LSCK+Q:EEɉH- 8%K zPyQqh?.17$P^99~lId)n*HՏ-`]dLf4JzҢm" RŬ2Be68hS(KIpj$Ϭ8qݿGOb2.POn{2VUhRbjԶ7+iJ6,\j7+XsN8 Nk•-0ܽJVLUM$`mkҋ,J)ARY2p əDŽݳNb`i^+VOku1n{>#Mur[J6:0. ڲT^ͻ㬵cB\QQHB*z^h\C!ar RYR,l"uy+pSC,4ֵ!I ^pl˚ER'*-UvPMjiwf[esKOaÑ҂k:FObyo1b2Lɞr:Hh -52@\?K2gƪP{m0Lۯ0BPP#W&eVfF2mKC0ꢅPմ&O88搢/ØJS+5$Ais6gF)2g7㳻B7SP99º-lsL?curӍJ[@3`o>[qԫr.RBd{i,M-IRڨXIU)fFn6˗č>% qrjZRH\l1q<]ZxrjUnUXҭn ͍Fg%vSJirmnmQI,P(y|yyr~yc<˱p1! Rfl[U #h zVˣ=#9s:qzHןIx="?R$J8I1I njlu :F<Ë>=O^d-8ϩ:v<(K[ؕHݼ,:%C˓]e'ۡEjCEإTRTkNyƬZ㖎FU2Cq[ZM PCi+To|)$|]y򋎹$䜿~fw'ucOC4m}N;\AƘT\[/=%R{z/wId膫\ p\jfg^y5Wޞ:]Oxi ,I iE#QQ%\u"!OW ݻ_~{%-FHm̘ڪ~*y0,_⥙W}5քDZ{H 5ᶜM2AFEntxvֶt) qDVyNqF u/L˖.|(Kk[n44C^}gn0$5* {1l/>bHlp]OSJݫ[\M2#Dh6rxjlMb_")2}+͜fmF 9$iJB}P=qY83yɿYALD<VJZU$ۮic]8v2 "S"R$E[niY$j\fqxfohuFB#a!Aiֺk7JʲKCnG5#nLΉoEFJm hl@3;LnXi/TPHQ (^ [ >ߘefaNv#~; H(i_ժƊe0Qt/GPTSMggnVŬsǒ٠yț}toH G֓NOwc-F1#㹴MhdRCaQ_~"Z gYBE"@#cXQ5 Gɮ-s]|+5zpl[X"=y𴬠*\ݚ]1 M)Y;&>d4[Tkp2a+;+)o1%)r!?,}5řd~0Ŷk#bܮ#<ӯePX$MP~' >K4iRmN =c@꽤(/Xpl /x V!ldAkZnN J+ kA|F,ڇ(l_,PZkx &Œ-Q^L[©Lb(;vV> *{i 489 =] -d|h\^ԧWr[;7SiO'ynN$h}쎚5ø'lbnگw_4%KpY S+rvk>f;qb`*ZZy'yCn25 Jpeʮ2[$z+F\˳1T2TRONPqh&bPo8RSMzuֺ&hKQ) ̅X _z!aJ4PNլc0s-]^X ʹKBcna6zX5whԤɟ$V궀BE;> [9Elsg<4e;HeEMYPB_-Y\WnGE7>Amf .Mѧq|w d rO(@RXvf#x቎$'T]q<;ߓ1ˬt7XvּvL{>JRSJQ/zfgXuJ תu,8>+ =S4Ap8QEJ !gOgtFZLjkRӼY-NMD{@F}$ ɶ}53i9I%'YSf{2pȎԙ򒔆Uxl0BI$ӴII"KlWhYȱϿLBk³qAVJGtk=L7-<&VcD~ޖ Cu}'i-Cq認 w;@D|b́R@ (ARt>"b9Ǎ5<6YnJ][#9!26Ox|N%-χ@ěXL~cx(SmSҴk|E*vrOb.b ݋UT">(o]e\o=-sQ2c tk C@u,%kHܮuO?mov~<3ҬܤiE)(:ANɡd'"PU6S[(4dؾJ?xŁ_EbҘ~ bd ˔]uũRJ~SW|]Op;(B{z ȸ}VA)T?-0plkm%]q̒}PR7E5!I[d(+ۦڸc%WJh(tzyiOrU8J&-Eտzk+qTK3mWKD ZqPB]lՐr6GjYƵl:_1\Sj9\lH[AH=EA"[HjHJS(,j+O9\_׻Z )e-J4pգ$ )6(9 rC ˎ*OyPF7aܯdxṱT4=\x80-5mcre'xm6TJz@~!DMz i .#bK\!ƔR(SIjِY. l͵ܣBq I rN'̖{7uԙ$(jBOv`\ekɍh[JSQP\u[a Hnu{6G'm]]w^]5tOr :UYv+u=׫-f'a2 [Ֆe Tۉ#WQ2"8Ws8۵BdܮSX@ڝ6J-6U-Ũy:C1y;}VexjZֺ ;Ԩw|Aa>S0̖DňhuI4$v;uXɲLjZucrR$Sׯh,mP P3&;}З}BI#'C3*+_V#2К?SD:W2S֌HBZ!>ɠ*&LڒkYk0=sMG?#NOpo a͠Puj BeO윭s٠,+0WzNu{ z oU?m=*i,gh{5(NO1[gA2#ToWZ\$ӯY?k'Yr7qkqy:+Wo\3ucn{uz޸ OOOz_Gyw\;xu~%69!r5{d͇O]~`A}]Ln:[Ia l)ZM~f#oyF:}6oQ#oyF:}6oQ'q+:?jvz{ m;B5 SXNg**KJLGR@QvJ^=A8k6oQ#oyF:}6oQ#oyF:iPRqmrCo\k6np̤e׶ṅ-e-F )+I$W#oyF}6oQ#oyF:}6oQ<{H'ҏlnq1VyN] :7jrwg XJ^T(d)(mu|7m(G_ϼ}~F>u|7m(G_ϼ}~F>uo_ܱp/iKRYmml}uj嫦;#(l DgÊTKAAke%?m(C_ϼ}~F>u|7m(G_ϼ}~F>u|7 Y x{8[&Ddxl5ȫas%f!ID w6oQ#oyF:}6oQ#oyF:}jmzQae޺iyaŰF- uqNj.4};x9wFкk6oQ#oyF:}6oQ#oyF:}?]X+Gn -,*[*l-HJ*@v\C*ù? اWBOq!ѧȯCoQ#oyF:}6oQ#oyF:}6QY3h" r!kRS Mg;?3s1G,T=m(G_ϼ}~F>u|7m(G_ϼ}~F>u|7 u|7m(G_ϼ}~F>u|7m(GX.?hgb)S~d!#hؑJmM\?FùiIl|Ί`YmIܓЊk߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}NN\r:9r7ˇ߇.Sӗ#~}N".[X&f|KR**uВHO9٠F'vʸwXA#JFIFHHJExifMM*  (12BCï% AppleiPhone XSHH12.42019:08:23 10:06:15 RZ"'@0221bv     |6266260100 23ޤ4(< 2019:08:23 10:06:152019:08:23 10:06:15/'~E"e 2Apple iOSMM  .(hV               ! # % & ' ( bplist00O:Mc%=jSM4| PR=_x@gnDR:8M X+ME<>.*VPy} z $Z{y{uklq $bytttqka\n YsonibYP \ljibZPDfYeep]qqRG<[Kec_K@6X Xdb\G<3Z ib`j1\F;3w[~`^^tbNE=6vX bplist00UflagsUvalueYtimescaleUepochmnwG;'-/8= ??X l*@ q900n=  AppleiPhone XS back dual camera 4.25mm f/1.8NW K TT& .:(. `dId# JIJI2019:08:23A http://ns.adobe.com/xap/1.0/ xPhotoshop 3.08BIM?Z%G?100615>20190823720190823<1006158BIM%٫.@БqҾE<$ap֑FPG_7'اZ 8'SpH'D!WpbۂS=dP)F $c#~u:5w(\G$mLS%. )fS XrF*b$)w8ҁ,0  ?z'I.b2х߻pt]U08jK/lQPbL!+}TfmGaN^ey\ A׷^5%@|p@t\AM+Hd"s9Ҁ"حB 9X̒K!gUSIsXS]I8Ӛ*w(;)d`&Kr#c>ya% $b`sRB^$?'Lr2極mnL9 nO@!kYdwpo9ZAԞđtf#*nqݩ_aˬpOGzc.4bJ6Hsc$\0*r?_P8۫O-JWsqPpy"O d;I$SG|N"pK3ĂSs+s3UeXX,~?7u?i\*q_R-¤#eY~rCs;z/[Hhb\Xx: #` #NrXsk(ᧈ:%m xm?* y*,{ l A`ҁ Evݽʹp'HHP9^IGZ3EYd\ stU!71"[t;Nhӑ+ p${{zfIBߒۧJQPE$ s؁oNjs,*D@>gϵ$Ɨ$#:e'(wp=2Gǭ^F7g݅oIm岠dW[!ξ\@.p=?ivY0"BN8XEC6<2F0{\#nUfgm?8xZ13 x'1#=A4q)2 `#1OqҟWg"SljT!]ib$`(Ēʐ|8=;A{Um 0e z恊V+ $Eŋ#.p1өE_{&yP}A N8Ӡ8VXθ0xackI2<(H(B xȊɼd/n_i9'מօ\,/BfXe +]oBL T(*wb1Z,ÏA1F%1$3X٤{TrXGR+X9ڻO=N#e=ͬs9$H sonD J5k.4 d%|c߁Y 6<>GBG[p 9,y,ԟ)U1qDy$MXkD{'j!TwH >&]UAFpIZE%$@DN;c.33c9RFP:Ul4Mh&d%WrF>XMY;}p80qMh#dXsFEXy" e1=9⭗g+Y7t+0۾|g0@ UYU #ynPOq<2G<-*9X&]ۀRy\;Hą$kv˿yU$"zg#fbx?YTDnͳi;39r(UHb<€ޤ-lI>ѹ& oNp[0p: `H~T<r8|Wd{HS4slSI(ax`QAۑ M]P:na=Ͷ+h#X#EE57iwpR0P*F_JxOHUPJ]FO DaY{S~~ye;Si1.~ǦonA^p`6޲mkO>Des4!}z})fL̲nT}3] NpO:-$7O,(rA$XZ?\,:6sLXd0zzַF`M1* (9$L$g' 9@;^PKC bvm’; ~ZhcZM2nR7@6+7V)+>U?5َ,Ʋ3pCz:U#B8i$m;zWx'Ə k^-P( 8qZ٥Ӯ56T*͓a{թ'3iC1̈H&VpY'< 88Ut1 sܜt#Vd1*G 2;=:MBrݸ7%rG<$k>T+,UA=0;pj)s:D^1Ln;'95Q R&>w(l|֊64T>EcbG1X"W^Au=1L[#19ą0suKj l/RBoF 1l`JwI4BnȽ9P'2 ؙ!H?ǰr¥aGbF8Tq$w K11#@NҮ"L5#UR$pB{P; c(sGj2"ܧH +-A1R dW܌1aSE*$P@}2 '{sJB n%`* aP3=T7|X297(ű9*IUSQ~q Õ9'HV `v#ԊEmd",ĒAcd󴞔 cWs*L0zwV-< p=u橡h3i1@lr9>\K֖!o EhZ%8V'>uo9rt}F!@8s瞸H:nD"2K`@@'gm{[yWʫ 0),i h|׌#ޛS N196;ln5 .\vx;})c"Y)vV5AQy!9ܦ+y= (Sada$``uE\d=O, #Ɠ1IH ["s׾x*մ(4EG.(~;Ձc#'l̐=xmgM XȌoaPzzzQrc`e;;qo`i>ʰbL_oRXדM{Ѱwo/.r7nŁu1057N\]I ·9=(uFʃ+1bpZIP.MôD 1l6~Nqu#hm]W w2Fm}>Z@/bP4Qơh^J8=x횒=yD BqUUFkIRd!ʇB&pQja,gkyP"eݴ ^㿮(h-ܙD%C)tqR}iWULJswv C <ۓ 1$_Hv899bu,r (Ow:: sHbC4\"͑| %q8eyn"] hK1yv徃9b0h- N|s= ^FuJ23{C9m^PiI'7o*>;8ݜvdumplHT1$Bpu-O)sߒ8n<.љ#nTyx(`G![P^FaK;p ${*ߙBl+y(ry29}9"}"0G$F$Vl@H+yy:ݖe%}fdkH&ȅF¡ep?: VVl`G9.>^=} ['e#T@NӅ?C988S M 0l[`H'XܲfduI detH2rd-co LJa A ps=I$J,䝄Bq$D|*̤t NBWkI]v('v/-𩥆m3aNz>B4F?.`8֤0w2/ 9fq*E $g=(28@Fr2z@["(oTeiF{ynO߳&}=;O3u)ܟr|F~ڟaO> %q ~ہ30p |'~.FI5Kۖ2]Hdrs=29szʬ!QW}Pe|`zֺuxkDM*LXww_Ú]{#?1'.~D ~sZ77Cʠ8 ZXrFJO> %c-$=. <6+ 3K4H"젱!HbX8ssh'rB0t$]vS1W4ciB\G9  q){o_6zM3B{G]IniozMPOF|-Q×iHmG8_?gcɦColIPYOa 9$f"G8hnF@u5O8S N[h-¤ymB F[p;n%̎nN9_??c x]k <=1<?c+Ucf",$[s6N7#qЩ>ӭV4F[vƱ.ITc'uJH8׏06VhGr#^OC~ \Zr inNS9*?9` 4άl|$N4i "6/9'i?O\JuV#! uQFzlcvPĊ&ݔ\@]8fr=9dܫYB FQxGZ[)onq9zqZL$!D1A=4a.(9a ?zB7{ΠA1f`OaAV+%f'c}>S:S]۩8RG4k3р^I'G|VfhDhINpI!Lv*7`1P8 'Zd^K$2Z-N.AVIմBh#] ^sC@x>LWn%O)2 O}Qo2J[yc(gcxÖUsm@%rR3#֤)ys!Wσrxt͍ _1C0 ڧ1\a9fa.Y1GbFyyxиsyRDF, 2@'Ҭ,6<ݥvVRr@ ~1+ܼk9fTKByQԟ]xU H.B# :sPɖb{5 a|W COݣ*KTFvopc[;""5H²D :Aޝk4v 0U/A8uo$-ȍDnB9CL {|]fA\"̒2O$$f,e*.ႸlsMEeHw"ʲÓ{d #"Ya~\|\HIbu]D$AՅWxR\M!*Y=瑎D®Rwj!(73Ԝ{)bٚQ&0CmsDD-\AOfw>mˉb_hc꾝*I-LVuF98e .yל0$X)y,21⥴%GX]ppNq99#fymFP5X6|9bq6\ dzcܚC4Cr.^H”]۔Ĝ==jiPR&ft<8p_@ariFaS P&u\V)ĀI`F?0~Us 4Q۴"0Åi#=Jq{iks(r^,qervmݍ;9kM$+ۗ3xb%FI2.|H' H= *帒Lu]&Oτǩ9QV! 3+TP0\9-;d̂HfĂASۭI*ZeVM`Py!Zuż)ʱGKNv eLƏ vkVy* N@U9`{oJ!Vx2B (8ppr{j- …q#d``^O{7 f$wH훖P݀BTsop.La ` ztsS_.{Z\p"ȉJ1z@hF4_ZyD Y(zzyF vdO9<3mŲu'{ s~r<6O{'13&719m 0 !E*lx&O*W3w@یAř;h%.7`9.r3d"kIʸB!څ,NNO# {"`]pvwu>t'񚒏9 |988FY@294ԶvTxPw{>`(;Nx#;S/+챽yл wg*oJ|rm`쓜sUs I rXNip6!a! NsO'B/Y]]Oocg^N43#o\lem?8mWE[!fOeel[G:0#8N:apgPY00rO@-T3g᭴ wocsް]cl|(~cK|#5Es!_k_kGe<3TZMcm%n^;x\_^Q^d+9?e_/lףkY0 ^#O~ v x>; 8GG/##uf>#^y? xV,l( 05ӓdN^5.$g;:ti\}ɮO8𧀴ojiVW|?/,h3kO˻6.e SgV񨧹C 0~ ][yKxh鱬@#6; چc5~,3⃰-I=0?!]?DDc\N ɐ^3K|rwZ]Eu?7-{;(2g;]_x}&8F[Fu< =+Oo">.uSt)"GN#=1_-oʑ˪R_*iF[h u+U|{$!B4=xrpI< [Ś,l~Om rȥ&xz]-7v,g%^8_sx7/"i+[a?7 "?*Gl* ;xHGy/^ lñR!F^ǏZCdsށNN 6ѫI3cEM]5vH{}o 8k*p|ˆ_gៈlݍGGFuC_\7f~BVU\edJr;׹h<,EM-p3F*ದg#hZ-+4 3bC\=ETc̥#\(qI#׃Z',|sH>pC%G$bDx=OgXAnY"Xy=IN'UPK0Ϸ>jp]Gz"؃q 84fwX4y9vV*)˕bV6;F'< \xy$vDpn?>YCU6'vS2@8Fii-WZKc6s ^q1~'և|Pl8>MczBSRn$V\*:w_Eguqq^f&$O JrG6CH:|$_kj敳 B~AgD1XḆ9>e/(9%Q)luyV \jM/x$c0}8=˾7Ms:Ѹh|` ~ɯo!6#>sq_)PZbr8F{ y6{Up$?,HDBIh2.q $-Ȅ*n # 6@=Fi#Ih{=1,q5rh8p`8c?1Mz9`vmoq;qӯJ؞iL(`8$H\~\xVUgt*ϖH=8\I#In)pBfUr0NIBO9C3\HS!/@n㌚rh=1 (ÀI ^OlqChyh"g `s ` U `=P来QÚ'yqHFbC|g9w?_>.~z¯ k|urU 8M>hjS|EՁOs|ӐDh%~_/_R֯ B3)Ϩ5կ4ǧG MIS]E$!1cy9<3U^c<ᷢc$Q:$֡?j>K.O).F# J{s``+b6>`999kCͳ[V6mY]$g5Z6'6C~`[\s xf\(ܬ 9.s$AfIZ'Q*4e#_-w'8QazzKkx╝“&ܐ0\sHBa͹db@c'9UDNeٔ|&HI1I8*6Kg{hٕp"w;B(d"Ԙ2;F݂9}VEhd *'wa :٭»<'+]q0u 4{g!wt%6>hG {h>\I>rTA\J-r҄gių#ukudl͓\99/GO1i'#=C_gú,j2<a 1oi"#2?+Tw}^c ⹚FK}7c|cޤB}K|Y;;P pvzb4*,;W״++Y?j^ڧp._wؼSi`2?_̬[8;Jס^Q Ga~L~6'/ LJ̠KrA'Pu>3muke0s؉AnsֿexOA-yR+vˢ0YqxfIUWnT1ק/OFl=3|W%+hA涶?( Q,3@`tzUr 7a`zYFr8,%N10Olg #hH˿YU=A*9lWa2svtfVrvZE)Bv8zt{x$olHd㓐0Gn2qm|ܟǮkOiHf~UIfÐ8>־(?z>Ӿ x@E]f]J4L Gf6uvg&~S!\=Myw tgF;UQF$خ][f|%+/h#H ڠ{޿?~:z^^KڄNRmM;I #˸#zW_H.O\))%\ۇ+ xg3(Qy8#cj҆TbiMxƺ׍5K^O/3[Z!RܲJ|8'wÍ ⷃ<)J Ӕt#ִ |Gݯ!{; a#ʲ u+rO\k/l;|>-O#:c0Iq2/<63渰a(rٍ0#8'׿S୧|F߆՝ʃ[^K+*ha,hPLǍzn}7>r?g&Гt2΅U3qGpwyVѮQX`8{`ۊxL1x9Aܜ*~P.2`8Bx's]d2#UsI <#Hc%oWjDvaNH<s (h'/ $'8011%8f\Āg @{'6/>|xp1q¿}HҿgEpXM6 珡_)c'9#|/?O -b7m*Q!g_'\[hyـX@ϮsV)>'mHJzvq"1K3"aٙL{I8@׵z4?F+D A#FA2'< wA4sx!Ro9'*q۴Rx(E^A($}s<@;Koj3"mO#=89I-[a Ұ Qr ~b$ig,E#\ ®6($I D6W0bA~O<z Ԟt-f{m6&> FGHAFyױntEaWl`pCGͻ=Wy"e;p 71l.N/,'6[+ƮРnH.98zt%oFt`>_H1Ooī7{$rMMpH'2zk~|3(VX9Qȿ7? ͘uHnI=q^R*>OMs-T$ن89)#CSF4sB FFAa~Xj`\K|4DˢFW+UI9;NDlEuc1'a\3O!Ҽ;luuΐ!H,$w=O'AdT$E|[qaHw=}|+{ڤ{Z -N0; U&#jT}/Xgc #fK79k*@뜓Jw 2x3-᫏d]=:z5zKOl2@-|#FN[ucD'#qbrFޑy#-~N_?ڼWďgˍd憾iLላqDrA5WggqWeP ӂ@_]~R1)dB,ˍĆcg#k;u`_d1$vurm`8z1u,]'ݖf-gjxnD>byr:O 9RLH#P $`C۸<sO{!yƳ+!JNy1XĖ-sfgȗi!c+3 {Gо1|`ФQgk.b88;{[2e l.~>S׿$۔`=$ |$?1%>wd65Ж!ϙs} ׾yׇ帉k/Ѓ~7AGXH$ 3ƮZ=֝y * u8m#sN^Sũl_ymu[x8uCM= ܑZ0>U0OҺ-xKųERU^Ns }Knkާ#մ+@6eiC* 'Asqym4)YGtXFFڋhҟHla@lIe 0sZ̑4E(fF(Tn$z<*$˰#ʴ˄iK #>zf/y5U9XI㎘c%QLSfY~c͋R td-*RF[;-1Ԏ$l^|,YLNck~*7(qZ]*+BKIs+~ҽKῈÅmR~}9&_= z)]džͰgTG#!@ڤ!N$1*1@# a$&"dS<' H#ٷ6oS-{ G䌜7RsO -#4jJKa PGň'rA51I'%L$@p8[&SӼ1DwO@ $I'>@\~ wX۵ڱqi c 3e~$/ x?ºG.8oL䏩ɮXT㧯<监ž> |Wiv_Cl߻ym@I8KK jOs.'q''Gfм/7g` <0<־I;~YL #<9J˒4RA-ׂ8Z[`&]Adio8d(I#"06/lc> Df8ZL };kຒT+pp8= 0Y`pW&L,.sSFr!1lX7`(ln}Јdxb0Hʃ,*[&2xyO`T1cV2|c>6׼ KgU:!Iu#w̌W&ZW)q4o$H\2[^wQ(fPNG_0=xkw?~~|rǟlQkd>f>r;kڛBD_ l]8+=@Fz~P/2ܼQ.\[ ǭ~W?<5emEReGW0okƨB|ٞ9F9g? |p־5[YfH`nIP7.CIu|!xö^-]чGQϸ`yV_kqrI-bCe`#wzu3KO kwy,hE¬#<֬#VRc:h̊ !!9/&h_d4ݣ+sFpr6|*^-7!:s||xSg=1 hs.>ZxV\YάU>h_=:E򤘏`y;zJd v% I=GZd{KwGBBc8o(f+G>g-ec`7)\18 qQObC;6ؕy wsc$j?*wI̻رwo8#QppI'[D,"XA" 2nd$|C(EufQ+7Nqt9'^Y&fR䓷O^IGE#+2Eqq81Ӵk%'. qS߯X,Q^nt(LEpas1aQ̲ۈ|Ǖu cE\,F>Ek[`e\0\c<:<<9 k;ZꑢYy,Ul_*B~Wמ-m&Fsq_4?K2#Tu`98_?G:gmC+IaF.=3Rf ԻvPF/G9 sQ]]Aɲ5@jgsnU%e 󐣠\x#&KjΗ>ts$ eW!10=,[Xa[xR2dP `чlg5ZK9&cX`?OvjmbU\*{mu鑊@>=ѣWhy~dq U&,An&i>gBdP~uN1QB3Qteg92xQoȒ+USܳgEppF:qݨxOZ|KoG..uY2H]q$;W$׏[L? Na. 271_YƧmcDj~wV#8Lg߻x]ԼWCS;|H|OOj;E .>grs_i'[qo1g|HsV9!>(|F+FCml7%# L~\@c1:{\WO=5JTUW=m9a?:=͟!VEI䤇ѳg?ťNŽұW*w/9|[gQަp`p>ynMOVUi%yW()'<j@Gx._y[ 'xռ]Kú˔N(㟜`s\wVʀA:`q'}OwZ2|Iw-*Dʳp9$ED*$|HNH8"cY-٤Hwo Jqc۹&F Uulg )b$ZWwD08ْ)lsX$e+ ~^H\c?)nR,Q?7B.p,I-hI\+G i_ ;?Piz6HKy<{?fxdĨ^Eif}BiAxIkgWhǎqdgrs_#PZW̄FDcp8pq훰I )*] o=:ܜ kV'8FX3.ZPANž9O=~~#6N`Uܑ'8`R&CŎpz߀svL쉙 C*% m{ Jf[3\0 NF1'+tS[繢-} 2!34Ѹx>=>[9;0S"dcn[<`u$3Y;_2FHPU;Ӯr}&*Q%d#;88U3#ƥR]fi'\}FSfX~P(Ƨ.W'qP>rv'5h˶Sch9s.X=I{! mBUbW 110qe.lLXd>dn$@۰~ oG1_1۩~5go$;c՛uǖwD;q?o? emAkq Fp B;ֹAJ>hp3ZѬCh>l[5,13]"RT*Xe#og }:ֿ9l c-{y>E*e^I;p9& > EDUBpI81kVKpx!F3q'OZ9t Fq EmZd"$3|<; Zlx94_N ?1<=;+~(o'dy,'T (G>K@7i_N2P v^*&OѶ="~ ?",ź.B2JN>*<2")q0;OrF(ـmt B4dg''9,C+)6 i(25brS:Q ?Y1 T[!G#pOj6>-tz`ddy=#_+H$>Pu9d%TuYf])Tu_4ɟ/E^OefR'rOoB!G& zgifo9,{N |e/֐0Z:ǐ+!J$㎣9_=+Ex@M2IKn,l =p=r:RJ,99ǯzr eTudx؆1\^AdsĄ: U 6`x"]@Ɖxm:i%3Z61޿x ؛1\"TgL~^&lvrG?|Gi@2nAs_W4.Wiw6Ob7ycL[\: l峁zS5iEE q3ݞH1ܬM+*<mcUkTf}d@IϡUbHPc#Y3:qLG+itM#6@f* >5xEB͆)$0:pOWx'_Mr]wj]rrW |v|I"Tcϱ|F^ggyu!`cC B>tB8$do+ociO9cUכ88C*~_(Y5-Ӷ:]_'pKwʧPG]|,12G^:b\hͩx['qv=}{T>7XKRn{F1QڷPQ< 첏vZ|aʭ-}J9.:wR^x8_gЙ&2_C'wPyW{ aN[1.9'"~?˷"ҳ~ˇ>MR5  v<(Qۓ+;{hѺe\pqf(;2CH-Zʇ#L)#Ko*FWyd'ypkCc0t$ Tr~^P|N?i2kVUe;_D/-yjIf899BIo5It%2)6[&9ǵ .ƨdy,_$NU{"ǰF)KEu,v[\y*bp:.s_lX0<'+1awqx|<~~OP}e:9%E\̤qT=\MϞ?m|V@[^dŸ&y]żh*9,rz~=w'=;413=ϘH9'`}ql"oDlС:x|ȣ`F{ _ۀ+:Y3fS*39LQm?199y2e 6(y@3s@Zhȋ4Xh8<6O^:QUtV-f+tGe ܬ;F8,{u"KE+HUQ.8\!I5'DRQ@0\{`N;w]R]_Hb0CAjwka/aDI`*ecP:{׊q/YPA)/JBʛn-Xdg8^5=*/SI߱tFOv*Xivzn)xf.Ѹ8ۻg-ے?*JGE26s094o9̊b,2Pr7t~nH=q?Jdx/%?ns3nL``c~ mO 1cp~b=sxGP3ЫĜsל׼x>  qy_^H0Z@hyax1$o< 1(`IR#0A 990C:Q$s#%편;5O,&pxP>l޽Fx)㉎s͵:dO_N7?0mYWqrp[=~84s}\dt8}v#R>fct?YY^)WiuǵB$xr WD~~q\BZ2 Djq:g{ncѿbψzN7q^Cwhi6m*GlV~ &kX2ҶzW5(%OD8)`0h2{֒qH<ʋv|`@6eBJ9?ʮhw]S]8ķM@ӄGbG r,u4Qڴ2Dw3gk.A '@dʎTe9ǿDx";R]1 =y@Er+73LpLcѴ$m<ЎzUrJ$%Whew^3=Lv0F,xpbf[$@9] ՀY2Y*`=" b{b>eٗe`Yn O;zAeh( # `yfC3FQfDrd8<`խiR+,0q9ŒJ4R#1-LѕG=8s樏k$;x|`d9زYJ 5,sݭb,7#_yn|ISk(o^! 0=G_&~wiU湏v +_[YG xxᏆN_| H'TP9|? ieWf `#t9+`G}òD-'dx5Wߡv8){¿P>)I0>&q99|w dfX/9ls\ӟDĥ"E29'Q_0/O$*sm  sztmO^`m2/wyp}ItR)5UQ Gޖ Ǘv#N&Eq:,+0،2=~M4oT}m\^䗑;?/o~7$|lxI5%SosG?~ᜮ~RF@{W~I9⟇YtMɐ0)?.1Fs_ \,ƯH'pÃ{g־#i>&f$`llJ0OpG<-DJY~BFӍA8> ('_-D 023 9=$^>1XC)p`ީ&uYIU?tt-tqZ]]M `TϖFBLrGM $Wx=c&5Vl9T<nԐ@X[`y d 灜g=hk5rmB2d`\0SԌ|2~>Qyb3s:޾dž4$` 0щ%a" R}Nq^ k 9fC(XASv#qg85^Kr D'rʂG#\E,1D >]J~Virg~"xkWouh:DkV60rrG0ʏq !ΝH?Ynf6D6N̤ua Nф~s j@žd(IQDL19-՞5Od Gcr F!δN_U 6>cͲ F38+> ~!Ei59Cslʊ9S5A_qo<ӏ G!VxA=Î}1?֦UIYt t~xI߈}"8کH$AֿCL./9) W'Xxš5Hs+BH9FlTR$.>x8P4y`@"bdv;T8LH5XGo,sn~@GEwWZOP `w hMB UPw/^=?A^Ϛk[ .!9eU]y'UAo,P:re$c88Od%av;9Ǡ8YdI"K#F0NOLn昏B>>)xbMy^mԜ|#~ڸpOnx2/o Ku 3^B t}э`9~dfцO|H_ ?1?l?(ٸTXqקONF}>G NSs|׳6n'ߧs^E-j#iIif;~Si۷S֙f1͔nBewV a }S|.-d %HQ20ILϷ[mp@L,{BFJ"syl?G?d2xe%! oa^#;Aߥ| H`7sW1q^EO3) z<$S"YK~aOLR䥴%) pL~VRX3j; G_$ m~8 M,/3G1YIsҽVx(k|)€:ҿF2sY[O+EG ,[+8qs_yW4)?($JC<"i-Y#8 +Cςkk"KvU*= {isRqxWA#nq*0U*t3յEp;3*^=+tk:@BY}ȘtW,dO4jml:׎z7ZWM2ar:cm&LJ p=gebwJ; O?I_0v=298 Kgۿt OOJy%p#R'}j $PL9v'i {is@>V#3jy\%w`cV<j2JM!;'aUgy-cHZ-;Av2Sjc& $# /`I9<Զ2F 7> 2F+p8sW%cUtrs ~BcRE3nMNT g=$+"Su8G$SĄ[9%deH,INs VܧJ<}OLsVq> n>cx.FsU~;gh(Wr8AFHXs) PNkXR3Ws׉g৅ƅRGdQHſ>ymܹRF {}kjLZJ⼏l ={ն!U یNUVk:~V<0A}v,UVΛs*;lF ~r?&1xw0:[9uw$rTVAR_l<[wnE T2' z +$ԡpy>*Ax/uazĥ \ bCw8-,K"Q0-qsJXX1irYF>\1סCq<Ő$3ɐ`%I* 0S% ZD6̑m*:FA;9=<v*4SfI Tܞj gv AU1oTpHrw=o!!C$d>HEԉ2Mw Ns1܌GkN LBX߂Hׁh770ˍ@*[J_{[+hbbryi$g 8"as3Y3xN+h+|.Kc#OPi]5ҾDT¬Ұďhܠܒz~ Vo?+۵~jq-1H=Ƽ ?GW?+ Id4rK)8<+PǧI,kR5>+ c֤ 8o,39s xu8i?|nW p?N^i,b}J"29烖ߔ:}_;]>ZmIChr],c!sgسCj ]\uvOa*9v{y7쩨ݹPǫmwu9:Ʊ4~dW2GaH#i88^:w,vgeF|qy(8#WH mk936w"_I$IǷ5Y!!{p+! .l1?*-ׁTɩB9u9m̮KSs`t#$ud-K 2`)f8S81 if8˗>RTG1\_\P z¥\bpx}xm/{9I3ylg9=McYͻ˷LKaA*~^3aQCY-^klb䤀:I" `* Ne >hX|]Nj8|xč`08$Ԋfmdaݐ/i ؟^29W)Ver+3z=^$I,[ #©Uz`O4/~(xba0KȉH<@<$0b$JT6U)xZ{k() F$a=k:Sו`~e/(&DJt݌wc0;'5rB3g" !d,7n䌨''{8?lE\Kt-&0c6qxF+rq9GhW K6v)%I+n w0,Nd!ErY_x8`jV$F,ʀ{8wRjMm3\JȁdgqA$vR!> 7 AlW̟75ea }+x0;{Ӿ%|5]شgcy?Ϡ$~7E*m^BEi,[<SW$MMdpTr3sY(1iaΊG+23s $wjт6@se[~Tt c$ Qx(hT;X=Ͽj*_df.+̿6إFBObaבҊj{dFK'eJ-#N;&g&Ӻ? ɆV4`{`ھz-X[a֛_ǐH kT2lc޾VQq>2R%Gay?_af A2+Ös}OzMy߆:GjQ:`~h.Ol wc^<,?|JU͠[sˠO~¸AfAdxWk6:{^oCy/|yϨ=yxȡH'~'= 7DHg+t!i%h& C -=yjU۵^O1H -:Qq,B:f'!^p 1Fy@(sߑ;ܜ<(qwP7 vߍ9<=֙"!v2 wLSh6i8n\s=0! \,Kg$vlqSF14d <?j@WXU W t89I%fi<q__ j1@#=l8(?/JcS 3Ftqӓ_wæ"ݒm|?(v5!]}eR|r5yvvnTEmƣ+C*qMp/qNH>>+?\̤i$q8WO$7?." *$M)c{'!C߁/`?ya48=W=xVb{4XU_.7$J'+TMv&`k4.Mp6dqLhh20(GsZ_0D. @Pʽ0z7Si9rQQԞzX-'Dgn!!p .8= UYϑpq d`ӊ0i%JHQO,Mb$u@'Q8Kw;8tz4e PyV}94" y1y\Pڟ6*̥ R@K1 ( O džۏ93MB.oMYYK>KyN}74w BA9;|v'+,j#ː2yQ">P K4sH0&x<2שrYl&̠mglB^2퀠c Eb\/wݸ;[ʹpy^|=5ߏi:0./e,2D),[_z.c6:.qXDF0@s9bK M QQU|=-c-ͽR]#i*RI>irggsi"j (x޿%#ZEqu+[xw?.:_D2Fy9) 쥑TWc2TRN {*LDyWP`:ǧ]'(W3˩S?ʊͶ8L'}o5,u$L9`|m9pcK.6(Q;q4GctH%m HRq]`heOAjլHrvJ0|@8|cRxJSpIu w=2CR:EXtPŁ9 u'֑f9jĽIJN}t'[Ϩ SM-/ 3rmIKp"~7u7O9L%C$RÁs$T*Iŗ8GS$EJ0| d9!,>&P"¹#$2z_كyuY0ߏ)u>&݇=xsTKm ݈8 A?*":ONd^Z!\JT !؜c<;w@dMD@d`#tRviC&űC O^jۤEݜeT%8w2:Z3> \)HoS"\LB}Iu[ &L?W^W C%ؖyog(BA Gj%q^^+GYc#@W!:z+QgHW 9{?)gpk? ~x=S:ub4aW'J$+,IzU Dc&SgbYtv0qga=OՕo.%`y3H=p uw&ЬCV{8 yq>| &t|9OҴ{*8 '14 fy E.|;K\88*+.a0)?iΕI-,^>K.`Y~SW6h Yo khVS4>Al99>~VFSxK+l, L_mU'oeQT.R(̓2Ɗ ,c&^OE ,"#젰ӭBE`UҸxÿt'x̳?eEsO?ix&)<;wVNݍ O+:ދሡX⏪Cn-ech;'W,.Y$eX#XӸMrfގU"ÆBv` yʅσ`9>,) qˡr1 +I%dxͶvIo~&:v#đyɜ8Qyj5E<;wFC4dp}Gj\l0A޼{̟r踰+e},3Y\82c '8=3Ğ<)^gvrj6243m :8 yr=:W8ȯ=~B׍k~֝4#$@9=E& a (9 byYImʱHJ /=sNd;*F %SׯG$ $!Y[$`|==2dP*nq"LόD0p$ƀ4GwBK dB|%l΍Od&Ox/Y> |Yu{4(_5p9x[-irw`evhPC? EGoN߅H 8O?oOŧ|, u|IDw`tzn7"X2uK$q_Zپ<_Z}G}?ÐBCf'Τ`ϥ|+nDLѴRf^ApFM}>{>jn<ܴc<&Ki.KD!x9rA^poOʜn.&oT6I|Ӝu0\7U @7Mv]')2I $%fP_#0*IJO$ u,K2G쪪>9J15nf 1ϭmKMl*B*pTcwlRy~xCg:\Lbdۚ?8>7`hc$Nuu)ζyi OO czDY`P8'N Ӝ'J3w7iHh/?|Kk6+KUdkn/gw8G5$쒨OψOIfxg{do^?cO.1|;$7Gds0+Edfܞ%f|4fYYB_s$/R0>^:¤ek5X7ͳq^v?/xE0!y3o^,voH>sNV" EF"AR~p H[z?Og۞=aIanXE;OUCr98ԏ$ RKػmʑ9!deGHHnBsg8큛"cQbGVO9;_ xF2kڏu3xr+ɣfXb< q rOa޳oߋv!4.R6`@bq?i7^OOLT"-V<} 9#Ӽ1*~X>G9IDn@`㎂$ݑ}'Eq"41d0=~֬rʚx ($$g'`97?- X$scURHuf<8k;T儲"K.ɏqg7en-%+h0|s(r<q0`iF63ק|O-њ:" lr2X3skF 8n<"H|bS]/'[}eK{{Bެ1$zqJ8 )`y,cRd@8a3{ X#mnH K98 ssj,<#,qZ{0qxH1i!Cʁ gk%FRD1g.^N@sj;ϭuڔҭt0- oӵxO>$>)n/afF(%)1==P]yfT [>9 #NGll[Y9+NRP{{}j4o2r$zT 2~!|9O ]x?VsܡRGYHWWKzq iy)qBԿp8Ǿ]*ԡ 5ƑkSM׬'Ln Sa8nEdň@crǥI>#[[e>a=:f>Kajy\XpnO_j^[H)(bIw= LywWՕ9^(S %^ӎzy7)nt@6"meAHO֠miy4W?ZOFpvm$g?Z_ ujC^=U/k;Eor%1c8Zrxűxkᵯ"6 h]k1+%qsfSPȓRsGP$IեR ӏë!YsoέspĨc<NO>W3j5hf=kbCY'>1[md4zSp>S9#~YX|)mT(TD^@\ +C"-cKxXvL>#;sq%wc֚ޠ砯 5?'-;׀'yڭ0XxW &#>6~xj~"kh/#D^o?\^%bEŜےʩH=O+Gqb+rFvy̡S,cq\$=Z(ՙc[Rh$O6=Fʑ!rsӂ1׹늂n Fh۟A^~-k!cq܁i}@%@>P@psxy*uLFWq%qrAsS&ݢv!9r3P3L ˺IeUgQdusR8Qmq۴%[9\0+ 7|4e"4aL*7, ex J!qҐh,aTʞF82N98f[2dP:t$(X HU.y]18) vj5ҩ #Z=*:Ry}) P\Kԃ+VUn0N^yO$"O$;2 9$dp=GP}G5a&U v5AnX&FQ})n!f2H*æ:84`('I#hiwFчz$ ?:vXCힽHfFsHPt a yh&|L| /BZC"22"BG' >HГc@hUK(]dddu#d28 [a#'Trzd&G܍,i>pUyp8 *sدE!|irF-u9^+IV;Iyk67 (2~~?mfKne/FҺIg_{r7H1 Hi#x\.mUrޠIG8[0F#, CpA#; >h/˦E̛H1v?w=0q$V=bHw;n`,zW鮹7|,tEuym Smy8ε*ݘЊ\t}liSALb5-"Cgr+||=eV$ֵiI:]Ȅ-@TgQ*I*NUe /u@u_ Ιh v$ gʼ>ׁ[Oi2;cqk#8q>#RxTVmgHY_)ʐ)8 #<b>wx͜ 8xz r@(RvnWғJN,o3fH}"ۇ2Ik|[P7IRvPckr@LӞWo/MY~. 5(t$#&^⾯ZxӾN׷D) G\fzTF;8VrG̚sj3tdvaX"7k~٤īK4% ӞzMϥjz/mK`*DȹB'ԩt~&~~0a{YΚpITd7P£K褩{=υxυX^sz0FIܤr; x-5#Lv>z=ؑ|Wq9';׉|o Kd5),$JRCF =q^}o  |qIbOg~?8S— h H9k>,~wo4-'De3+~z I漃D7QkWwpũ#FpqRN$STg< 4kDܯ.BY`>(daBobG!x9ϊ .i'_v"Dcg;X5 O |H 9=Ki: PS#;vapֽ_]~4˩kss XXö*1_G|'YxC⍐$7:~\leFF8npEC4)ɨſj^kY\]BuGP's/'Ҿз<,mH 9_WwĐ[74cy Tagz "pFJR>c;AA882ya8Qwq~#XY(܍ v9sElxkt Ξ}J`@,s&ISp5d[U3=0N}yNX6EhGRH@9u)ÞJ,mKĞ <7ZN;T^dD2koѬ\Kj6q8R$$G׀/U%q- B<N1rq\XmEcGn'5)^ZZݢρlh)x-_I y@9V O8: ?h)>z>^\j7^@D`,\e[+כY|3tLndo`b~ywqU|Me={ogkY嘕'`iJNuydsxw_L"]5pL)ɂ t_ >$ ǥyOCgNq};6 RuṴଇr,+60y֯|[◍u"48"TEPj$$d3 rKaʜ#Kgiyv&jLp+K!Q3=?%\ J]w$a>w`gsgv?fV+cj~+3~7K{%}"90˜Ē=R-M-wkhiea*W'8<ŝ/NuCr0 bj'@z~]j[[xE@ n9e<)~0=n59i֨=OF|y<6WϧqȒ*+v%J>wbX>'8P. }WGFdY-1EbdS|O |X>N1nbqZM,Z9ÆL8 /6[j3F.eGѦz^NK|e! [1Aש}'>t^i;TP*nqqX:(Ҩ䯱MMm-H#1ɋfr++sۭsp]hRiӦʴ|B1c5RҿғX"+{*&S=9]cN{c۴gß灵u(`aBdu] td9Ik%*pzZr,2IC*~v Ouk q m䓸gv95-nDec!c昔m/x_J( Q\O)fѫ8 g$vN@1?̉bOvsp,fq~^/8Y;>=*9X"n^!2@O=;u_l|l2y>{S<M2W=2:~S$O cL>yI)88\YL{[WE*~+:W_GG~ >1m&(T0j  @#6YLwMvAӌ4v&F| 0Qqƥ%QYSOj$?-޹zC'l|K%oOPG[+C7, pO}?ۋEgA>Ҡr+ E}tGړ9;Tj+Ӫ37$p_ fGL}- -GU~ 9T|e2: 'zׯ)&cZJLDG)_6 ;^'#,[؞Q/#\i8mB~_.cYouk)[#@TrZ~ݿ rMqɯb[jDmw8'1qֹۏo|?ų b80i~$z}A>[B:&)88àWkQ rCv6z3K!Iۓ)IdhKbzdIIxߋ$5&1=xב5]xk6tjs$5OJ @f7 ?eo6M)=)P2aQ J9,|5@[mx1~X#5å8\zםW9= XxC].c9% vq_H;-q*lθαfq|=q^%pF쑃 ?~ Z5 W!e/2S~0x]J{X b]cWm<U -Yp/~!u -S V>&THF$1cB;FA/@TV#_șWhE`wcb-;}&* +#m~ݹBqsҢeryw;GB1݀yݻƪMDMg:I'͵G?{ cX ?d!j ,@#Id1׾+O_/<!g]ev!$푉3X8٤_R }dUlg8=Oy˒ٚT^mmO =c-8$k7MGƃK+H[#±"8'iׯJ}~Ş0:ާ&˩$-5,i(Tᗅo5=hi Ԡ nLsғQzF9yTyu~:W$aZʈ(88, N<1x[֡,pk[.bWxڱ*8d{q-#9$c'־)k_T-F{'~YX`|NG$b\dc)EOόxx!h]<7ijP )^[yo<(۸7A>sد’ jQ:I<ΆEd!s'w\7xޜ_L ,Vʨ~v5%)+F%ӌ`۔c%>%TV(GK3[$=3ہj'Z>0GqCwrFwpJ٫⏇YּX.$Y:8#<ˬhW3[IkrVQՋ\c)9jrؘQf͏xC7rC#6hY ,QGk2̪"\F?"3X\`WGZtaoXQ 1ӟ֡2 \^^kf "۷.A61OcjJ.IJoeܛY`͹`G:|YN9> 4:|? nZ8/sT?7Ӛ'>l8xD'-'uP!G|٭|'xDŽEl%# :$$mPFPoxw rkC#(,xU_߇5~:]X6IU6@c$\׮}rkK; $j  HjxwJ4u=Vt2K,fAQ;Tmť\i9IXo GZJGg ֽWX Y1-8 c܌x?h>8-ynF>_}1FqMELkì.L)|a(_j;w}1R jϜC#T&,2@l2>o+f5kĂXCl˂AF  6\~5f㤑*qgJ|e4u+dXEP.W;W~8tٮ}{](*(^O^}K)|$j|boZᔨ =>oRQ"{=6" TcX?ޣIFӝ/Wl~.NUynȊi8w)H*˷G\`:0 GOk}ZVªo9v?/0m6u( <9QgC7Zx==u;l_,w[sЁP|©zځ|p8:<} ~ [ i,O,ǒǠ9kе_:ѝ,8烂8Zj.\z\X{;->W,Jh,%s.|/"H>ԗjB\82O>oٻlvώ/¾%@"fF9v R@:aҥ Z4Q^H}"sfF$$pO >ed(KMh|s]]_ʋ&Xp y2w9- d~֦/ ydz mዒA^ LjH܀e2\z+?> |i|%28_ĿJtqGOzDL9zҥIY-t~)~ӼXubUmrHzl w]iq|񲺜cC$j< eR87<~_wD-Ε?F u>TEcІ2KW?f-T*M0 ;/<8OCu$qxDףIo!:?\>V8]GBشlqҸ%R}l}۽'דL#$3_6??(E<82x9u6oGΖD uRN3JkUVK=Tu֞9׀\߳Z_6:nIL`pZL}wvj}_NuG bҸO9~fx +0xRGu$Ҫc%|Mx2.^+8,w9۞+8J}ib魵?`~!r_q v.#=Gn+#,χ4$ o$cQ܌wWM #.9Sמ8geB n q 1YNZ-5ד\M$I#ϧAN_*?"t#8ETE>MÝj z'MܴO,Ye'.OÈD/'b@s, s:R1E1ϵĢ" NN;sިCtt2NGC| p\n!y?JI0wc_-vUg~آ`JnN:Q*2!$H';I݁L$qG*4n $c`9sp?HLR)!6>pCp:UCi*FsF7d)=:? ,Y̾[?·v@lpv'I]ܞK [QxO[DM(f}<mmרb'X7 b7~g  (I 2@ b7G>9YHs-A[ =rH͘xflL1U3?;r1L)X02ʒ.8crG@ck W _mE|ʞ真^$dKǻ?0 I0vN0>ʅcĨy*܀?9Y >`ad Hc#v<́X#1RLtsY[L] 9cd|Áoe)|[O#b[!FlnlC2C nS? [wfl8}rGwV網\O+HA$Fv?)F)0)$+}w9 9V쮯db\a2(D`6rȘ\}'XwFgʻw@b Q฀:O >7FF39$ 5ɎXd @r[hr02jFKI`C$@ή m9c46ar x'F*HgBTTl0 p3N92,Br#ǎԌG pZȗ1UNwz~׳ԲMP7|<_SYyv4hX\K\g=*ZtxBH|YB$DuVrrTai==b@$0Ua0ĶqrpȦ h%FX0p:tu5UhU^"7!$,0F:0Qh YB\888tD᣶;mYa3DSd2rF! 92#q!B>t\@K~$.'$8NyJ# H琪퓎`*Kg&fbUI(H 0q8CngɌTPI^:f7jјT$39䑓@2KYb;B#3~S<}gCDYulHE8T8<Ԑ%gb6v19!T^gyZZE)wqw^N 9SȶG$; p\glV Ke1r"E9Iנ9 . wq OS52rD##x#rlb'Exx%ۼlGt:cgv+x|ش2DTa;|y׎!jwJ#2M#;؏9d?7Q{ !/gM2Y\?"@+鿎-׌)Nmelc` v<*:y|Lk2UAVR9ȼL#>|2MfvedrkhJ3dWYpITÜqkfA$'I# z+6 $)Rqp$t1N@/]U #)fa)+5&odyx낼JòK(f'ӚRtYc$`YHeciV)in/Օ#{ٵFz:X l0fn=Wc D72O#L3ށp@# 9G&y!e dh1n99֥|-d2C+)`>W!]D\rGwxJcW7w**sҥY<bfvBG[s_>#'1c 2*[89^sJU&7l!wl㹩 3,~^~|:Gl>=0p;Ro2D2SUHI{0fճ$S Iq?vS?S¿/ |m -;xRx=)md]'þ8=cG_x6-u6J$$cL:Xy0!rҿ6IS>ࡷ;+'O\m,HCqז8.c]c:t+1@7$%,PgllOw<_E k#mgjbq#;QW-{xm "#1Ywjuk؍JGț$A֨\xjY>Fa[D{\NygJW*?\g[g_-܌-V99 G+GW s E8ltzҼ,?c..O08yd¨`. ''4%HLPH 3~М,.4[0p|8 .عDĨUp gh޵1Xld:w}K8?}󂛤nxՐ]:[H]X)INNݸy4ɋp2ofaoY:6qvo6w`6nz k{/ʅ !t@6%Hcn uӮE] n.Fǐ= 2zd$/yS1<$p#j(^Q2sI]t*+11.Ϟ7Bz6x vN2>#0iHU9OJʶ@w1X9y^$]:H);@W#GAh W5ʖo`wu53y=d@7a2܁=rjխ7Ixsw0 H$pU8^Z+I!t[7On)ǔbH3fޮr8+}ӊյ{xw3G3j( % x9溊k[yJ1FܳA6]!p{eĎ)csdm9@ѡk,Qt nY˞sN Рf$9V2}sjQd A';?w=튎c!xLY瞊a`.[Lmk\^9& xHHra:ktp.kxbh8OvcČrZ2y9;H1jw-yr@ (v$if%k9)Mg6ӑڧ;LpcPh$ԎE,]'dۀF 2lb-[\m,]K`dci؞s"9]c[yp< wsWX>ԫ#"I%#aL}z3m̫8Q# s夀zb8oPpr<}zc\/+2" vXuݑ )FI0H"$m}d2~_NG5,iYQ2dwP2Ap!T{`.Yؒ85D0[wifHB JQґ.maf"63\ֻ_&W-r#rx8xOC@R-U퇔Hv x¯?1;״uodK_F㿮*)%$2`B}>@Ijщgc))l7PI,qOa$IsͲq9 w8mcb;nw4.3Fr1 rye]&_$6q{oo41Bp_ 1=EE!!cx;p;qEs$yB2+1c}}*y[_~|k :M>a±o/ɖA%^A Caӹ敘_Snp*#pW$sHq<օeI-h؂>Bӱ($#fGF8\]& 0S!;O%:`p3T #m sc$+EyeDZ6dBr&\.R?|԰I`̋@SJ tYcܟ~}Y2;2IlzpGPRFv``c $z3\ɽc|PF>br<.>RHI>PB(0F.:Nm zdiaH$s!oو޹Ͽr̊dm 3Ǩ8U 8ҏ6xDT`N:pqL 8fYZXdHPN48=te^/pO2,zgRY7HLW <=!in*g򌓞me#޸+n )<_h2<6 TAs~YԆ8rAր.b9an70YdAE+c~4hK[y NTaB15;\t5IX3ӷ>0걪;bH#$r<U2\M6vy|> 8IE !Fی԰/Q7l'p Ǩ'M-,dK4cyP;O< B01ߎ;P29<  F 8rHhwFV\98$JYL7H8 A#O͵ c;*NIE8B/,TI0G!RP- w>7[5 E38%NIx#uI,Ӳw"c~sc8|Ξrk%(7Y2 srz8eI6ơ ?>ZԖqorI$o%0*OR|y桑b{1I6;W#:@ #gI\qzc9=F-Ydk)AVGAЌg33ۉ HФY!Pw)N0뜜T^Io y((cXaX:cz.weH @Bc1w=&`Es)e2Ȍd;'h$zӢe|Sccj8d56ѼV+EaUTl! XaY!}.\DFBw4*]J *Xi  ߭ŤC #c_ބq_{qo]"FG>P*WO¥hQUxsC: fgv0l) d+I.yP1Yq>hY-kc72>Ars8{h(bH÷B00spyɤdge`@&hqf pAǏJ~g3%R< K@>cB3N>SB<.q8M:>mgh.n$('HB4FX\bDk\U9jHs`R҄E,9\=Q[0/_̌,::rd"c 9ed120rzҨ 2HXnD܅\|.=O9j1! w&TG\ j]tq[=6O'3 pGnRXFuQ0۞GA!$nXQ& c3IqldhDOp7Fw)c'ِ ‘1, hh ms-W$>(zT0=={vs#$`&TQ;I8gg %[cl#Z@$‚Bt9N;EL7'i9vQX㢌2}2M q ##@x䓜VE Gg K+av?ΞGJ;|Xxq3ӣP"Ğ!U.*'{/SR Zv^qT`Ny{^Gnf+̋qiwl6pi۴g,r2xV-%8F2,{̆b1Ёגj! m$mLi&|TAϱc ZdHjfƁG͜z瞝A@BѫJۂû,pGc\H%iRUs(gh|O;s B#o- x^Fn5#]i݌1wo-q=1 ,jی uO r:BdaFv_s 8Q^dS۰pB == 1Cp!.DRr#vA#$p) CTPs,AwOlP j]*E8>F0Apd=251H2OFUs($ǵ9d%аS qA9=H2A,J̟>ڼcX`eaFhT1eU6mˆL 푵1ɏ*Q#ڃ m˞[[H0L.F;|ac1$"<ɐe #*y@\+EM23ߪzqVKI@"Mb$oQ1ݰV O9bdq"ʑJ9c$R ,brJ |xe&y׳3PI)8'9MH?kMyFNӃb@3iaxbki # L瞤c񙼻h|!8t*A=4`Da©۰/6p9$x6bffflD@ePiݸpXs gœP zgɶe$i8ʐrHglBL4n!ee`s9waQ*M.ϐy[͓i9=*[|i3̓d1=''2^~ןUjK\ŸkOSH\ dc=qQDYF @Weu-΀Es4̩]( 8sJX scThO|~g?:q#= F}<.IUj1g#*Ȁz(ybF(o䟗{6EHfBێO<zUa<2|9<ك͸yNfd* c#32Ɖ y%rO㏘0qEhIĪweq'B"a3,_&PKc{tQy&/X(0)$TuC8= 4Z0""8 ;y9'Hfkb&#$ $@9?w+ 3}1.suoPhxduGPI D|$ܳΫr{ ߭g'>[t;4%1H>pq•8}}1pU`Y@K:s8DMSn'y@K#HU-7|A$ϧZkB{bӌDzD/h?7$w@#ee9cAG=G~3o((͌!rtV~%uJq^H֐^lygO0U" 3N3yE؀K1<Ս[wXcǛR?kՑ?YFQ9W%'A}w2",>2; `rx*t"-nOm֩䋻@fe]iĬYH [w$c8o'h PݵYߗv߼1⠝ ?ڊ=h qoo#\+Jd'b.[sZŝ]lU@f `5yvGN?%}\{2Iʢ)fїXzQw-<ވ2'V ؁*-QI |@Z*cر?jn홥`s7@#G6B[2T+*9ۿ2Y6BcI=jI$ZĖC}wJ[Q]0[Co2H%"|n $ \e9]fgj$v[sSȨ)'9bjO)[+l2.1~8Xdd7JjɅ# SY2@:LZ mXph3$lYnrr0S\v%њ6 l7 /@AR z*Έg4*IjxB.^@ 6$d-{dԚľ$k9;8TcLEh[+]4f14X=Tuh%]PdA-q1wΐ9O6̤GڟGKRQ!(KTXBѸj4x2IK'q=j @J@icvȚLkr[;_J4ĥFOL sߺ`J%e.ӝhb9R-S]fhF \5.i&E4nO!JdR3@ѹBiI(snzdہZ >πn/UEΟRCz3ݻ`\$$hW:X ZwuQ1B kyd:hcidۘJϿzݣ+k+@.xçOeP)C>Ʒ2seSj*NE"yd;˼$1fۂNFZiR|Ǚgפjȫ=$sSaЌC6ET6~l=O([KpsrTǨr1cP$\!"5g~R @;lO pTr}x*pR;U j LzrFqEb_m1Oٛ¤dpEEbqA{6tW$1>NO@F1OCoxvVa}ۣyuK$Y#xd،3y̤{ . 51_(ݏSy5QmR|?:Ӊ:| O-_ݹ$i$$1n3s=z Y'=2H!f!؞xF*v$~z O\9)44GDļc;I6yUJ؍ɉesFA0!Jr3s٬Y~HĐѦڔygGkx4͒K 0WCvO`id'jc/<#x'%WCZj$ΏӵE?$IfK$L$!vh#v:V ,  t 6,59/ 34 Bp $$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kd$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kd$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kd $$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kd6$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kdm$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kd$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / apւyt\Pwkd$$Ifl," (` 0p@"&)-3'''''''''''''<  tւ056l444444 lapւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kd%$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kd=*$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kdt/$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kd4$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kd9$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kd?$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kdPD$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kdI$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kdN$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kdS$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kd,Y$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kdc^$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kdc$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kdh$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kdn$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kd?s$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kdvx$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kd}$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kd$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kd$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kdR$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kd$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kd$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kd$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kd.$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P$$If!v h#v#v #v <:V l,  tւ056l, 55 5 <9 / B apւyt\P}kde$$Ifl," , l< "|&L*.X4ggggggggggggg<  tւ056l444444 lB apւyt\P s666666666vvvvvvvvv666666>6666666666666666666666666666666666666666666666666hH66666666666666666666666666666666666666666666666666666666666666666p62 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ OJPJQJ_HmH nH sH tH J`J Normal dCJ_HaJmH sH tH b@b \P Heading 1$$@&!B*CJ OJPJQJ^JaJ ph.t`` \P Heading 4$$(@&6B*OJPJQJ]^Jph.tDA D Default Paragraph FontNi@N 0 Table Normal4 l4a (k ( 0No List F@F n[0Header H$dmH sH 6/6 n[0 Header CharmH sH V@V n[ List Paragraphd^m$mH sH d^@"d \P0 Normal (Web)dd[$d\$CJOJPJQJ^JaJtH V/1V \PHeading 1 Char!B*CJ OJPJQJ^JaJ ph.tT/AT \PHeading 4 Char6B*OJPJQJ]^Jph.t4 R4 50Footer  B#6/a6 50 Footer CharCJaJPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭VvnB`2ǃ,!"E3p#9GQd; H xuv 0F[,F᚜K sO'3w #vfSVbsؠyX p5veuw 1z@ l,i!b I jZ2|9L$Z15xl.(zm${d:\@'23œln$^-@^i?D&|#td!6lġB"&63yy@t!HjpU*yeXry3~{s:FXI O5Y[Y!}S˪.7bd|n]671. tn/w/+[t6}PsںsL. J;̊iN $AI)t2 Lmx:(}\-i*xQCJuWl'QyI@ھ m2DBAR4 w¢naQ`ԲɁ W=0#xBdT/.3-F>bYL%׭˓KK 6HhfPQ=h)GBms]_Ԡ'CZѨys v@c])h7Jهic?FS.NP$ e&\Ӏ+I "'%QÕ@c![paAV.9Hd<ӮHVX*%A{Yr Aբ pxSL9":3U5U NC(p%u@;[d`4)]t#9M4W=P5*f̰lk<_X-C wT%Ժ}B% Y,] A̠&oʰŨ; \lc`|,bUvPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!R%theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] OnSu_:@ms !'D{   ,-./01;<=>?ABCFGJOnSu_:@ms !'DG { m /"R#'3vAIJxezR~BBDFHJMSbdgiknqrw ) !"#(#C#]#w######$-$G$a${$$$$.%4[@J}^kqvz}OBCEGIKLNOPQRTUVWXYZ[\]^_`acefhjlmopsv LK?R$ \5f_?8R$SQƤ?O/R$vʸwXA#'@ (    PA& Picture 1C:\Users\Agonzalez.PCM\AppData\Local\Microsoft\Windows\Temporary Internet Files\Content.IE5\EK193W2F\hadi logo.jpg PTPT#" ?N'JJ&(  h  3 3"? P  3 PS"?h  3 3"? P  3 PS"?h   3 3"? P   3 PS"? P   3 PS"? P  3 PS"? P  3 PS"?h  3 3"? h  3 3"? h  3 3"? h   3 3"?  h   3 3"?  h  3  3"?  h  3  3"?  h  3  3"?    s xA& Picture 1painn.jpgSxTSxT#" ?  A*& Picture 11See the source imageRJTRJT#" ? A s @Ao Text Box 5#" ?> B  S H* Straight Connector 6#" ?B  S H* Straight Connector 7#" ?B  S H* Straight Connector 8#" ?B  S H* Straight Connector 9#" ?B  S J, Straight Connector 10#" ?B  S H* Straight Connector 3#" ?B  S J, Straight Connector 12#" ?B  S J, Straight Connector 13#" ?B  S JjJ, Straight Connector 17#" ?B  S J, Straight Connector 19#" ?B  S J, Straight Connector 20#" ?B @ S J, Straight Connector 21#" ??B   S J, Straight Connector 22#" ?B ! S J, Straight Connector 23#" ?B " S J, Straight Connector 24#" ? B # S J, Straight Connector 25#" ?!B $ S J, Straight Connector 26#" ?"B % S J, Straight Connector 27#" ?#B & S J, Straight Connector 28#" ?$B ' S J, Straight Connector 29#" ?%B ( S J, Straight Connector 30#" ?&B ) S J, Straight Connector 31#" ?'B * S J, Straight Connector 32#" ?(B + S J, Straight Connector 33#" ?) , H , Text Box 38#" ?*   - H - Text Box 53#" ?+   . H. Text Box 54#" ?,  / H/ Text Box 55#" ?-  0 H0 Text Box 56#" ?.  1 N1 Text Box 57#" ?/ B 2 S J, Straight Connector 59#" ?0B 3 S J, Straight Connector 60#" ?1B 4 S J, Straight Connector 61#" ?2B 5 S J, Straight Connector 62#" ?3B 6 S J, Straight Connector 63#" ?4B 7 S J, Straight Connector 64#" ?5B 8 S J, Straight Connector 65#" ?6B 9 S J, Straight Connector 66#" ?7B : S J, Straight Connector 67#" ?8 ; H; Text Box 71#" ?9  < H< Text Box 72#" ?:  = H= Text Box 73#" ?;  > H> Text Box 76#" ?<  ? H? Text Box 77#" ?= D E  "?CD I  "?GD D  "?BD H  "?Fh C 3 3"?A h G 3 3"?E h B 3 3"?@ h F 3 3"?D t J C C"?H B S  ?enos56dE  B B B BBBBB\{r"t@=)@tiIt }tS=)StZ *t\ !4tU=)Ut | *t ~ Ct (6c'6t  :!t ;Sv'St2 (2tts9 t&itT&.t& @g@v't/ b> 't,bJ't_b}'tb'tv q 't#q#'t'q''t# T3A t T3! t 63 t E3:t! E3t"E3t#E3t$E3t%E3t&E3t'E3t(v E3 t)V"E3e"t*6$E3E$t+4&E3C&t, t-M # t.k , t/W t0}. t159!A t2/ > 't3,J't4_}'t5't6v  't7##'t8'''t9**'t:/ 0't; 6$ t<d#' t=4&z+ t>*/ t?/c3 tAq-Ft@ 3+ tB|tC tD| !tE* tF|-ntGt$ tH|- !.tIs* ttJ$t  @_GoBackc{c{ / _ w 7(8Vco]B`BaBeBCCCChFkFlFpF-G4GILTLgLrLM M\MgMQ QRRddhhhhhhhhhhhhhhhhkkkkxuzu{u}u~uuuuuuu`wew^xcxzzV{e{{{nu,2. 0 R T B D g i 8:jlMO,8IK``xuzu{u}u~uuuuuuuuuuuuv|vvzz{{333333333333333333333333333efmnnF F &&ttwuxuuuu2w2w{ tY%2Hj b [n[P_Ggvn=2-\9"9SZX"/Ad5rV ^`Zqa1xuzu@&&&&@uvwy{@~@@Unknown G.[x Times New Roman5Symbol3. .Cx ArialK=   jMS Gothic-3 00007.*{$ CalibriC.,*{$ Calibri Light;Wingdings?= .Cx Courier NewA$BCambria Math"qhz9zc <wEi ?124?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry FP8Data T1TablewWordDocument KSummaryInformation(DocumentSummaryInformation8MsoDataStoreP88NAJEBP2ZDHP1B==2P88Item  PropertiesUCompObj r   F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q